FCC opening probe into diversity practices at Disney and ABC
- The head of the Federal Communications Commission on Friday said he is opening an investigation into the diversity practices of Walt Disney and its ABC unit, saying they may violate U.S. equal employment opportunity regulations.
- 03/28/2025
|
Disney to Lay Off Nearly 6% of Staff Across ABC News, Disney Entertainment Networks, Report Says
- The Walt Disney Co. (DIS) is laying off around 200 employees, or just under 6% of the combined staff at its ABC News Group and Disney Entertainment Networks units, according to a new report from The Wall Street Journal.
- 03/05/2025
|
American Rebel CEO Andy Ross to Appear on ABC-TV Tampa Weekday Morning Show Morning Blend
- Appearance Scheduled to Air on Friday, February 7 Broadcast Between 10 – 11 am Eastern Nashville, TN, Feb. 05, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American Rebel" or the "Company"), creator of American Rebel Beer (americanrebelbeer.com) and a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel (americanrebel.com), is excited to announce that its CEO Andy Ross will appear on the Friday, February 7 broadcast of Morning Blend (abcactionnews.com/morning-blend) on ABC Action News Tampa. Andy's segment will appear between 10- 11 am Eastern Standard Time.
- 02/05/2025
|
Copper Ammonium Carbonate Market Outlook 2025-2030, with Competitive Analysis of Bayer, Hindalco, Hindustan Copper, Bhagyanagar India, ABC Gas, Gujarat Mineral Development and Baroda Extrusion
- Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Copper Ammonium Carbonate Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The copper ammonium carbonate market is expected to grow at a CAGR of 6.69%, reaching a market size of US$13.209 billion in 2030 from US$9.557 billion in 2025. The copper ammonium carbonate market is characterized by its wide application as a fungicide in the agri-business, especially for crops but not limited to wheat, barley, and oats. This compound plays an important part in boosting the yield and quality of crops, which is a major concern considering the rise in food demand from a highly populated world. The advantages associated with this compound have also caused its demand in certain industries. However, there is competition for the market from the green alternatives and a change in perception towards chemical fungicides in turn which will leave the farmers with no options but to evolve to organic farming practices. The copper ammonium carbonate market is expected to grow significantly owing to several factors fueled by their extensive application use in industrial as well as agricultural sectors. With the rising demand for food, owing to the extensive increase in population growth and the diminishing of arable land, there is a need for efficient agricultural solutions such as copper ammonium carbonate. Apart from its agricultural uses, copper ammonium carbonate is also widely used in the wood treatment process as well as in the recycling of copper from scrap metal. This usage of copper ammonium carbonate owing to its versatility nature is essential in enhancing the market appeal, especially in regions where there are robust agricultural activities.
- 01/14/2025
|
First Horizon Surprises Four Families on ABC's "Extreme Makeover: Home Edition"
- The Memphis-based bank provides crucial resources to help families thrive. MEMPHIS, Tenn.
- 01/10/2025
|
Gray Renews All ABC Affiliation Agreements
- Atlanta, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Gray Television, Inc. (NYSE: GTN) announced today that it has entered into agreements with The Walt Disney Company that extend and renew the network affiliations for all of Gray's ABC affiliated television stations across 25 markets through December 31, 2028.
- 12/30/2024
|
KGTV ABC 10News in San Diego recognized with National Press Foundation Award for 'Cost of Care'
- SAN DIEGO , Dec. 2, 2024 /PRNewswire/ -- For its yearlong reporting series on dementia care in the U.S., KGTV ABC 10News, the San Diego station owned by The E.W. Scripps Company (NASDAQ: SSP), has won the National Press Foundation's 2024 AARP Award for Excellence in Journalism on Aging.
- 12/02/2024
|
Disney, DirecTV end blackout of ESPN, ABC as football season ramps up
- Disney and DirecTV reached a deal over the weekend to restore service to the Mouse House's “entire portfolio of networks,” including ESPN and ABC as the college and pro football seasons kick into high gear.
- 09/16/2024
|
First Horizon Announces Sponsorship of ABC's "Extreme Makeover: Home Edition"
- Helping to Make Homeownership a Reality for Deserving Families MEMPHIS, Tenn. , Sept. 16, 2024 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN or "First Horizon") is excited to announce its participation in the relaunch of ABC's "Extreme Makeover: Home Edition," set to air in 2025.
- 09/16/2024
|
Disney Deal With DirecTV Ends Blackout of ESPN, ABC
- The deal ends a two-week stalemate between the content provider and cable company.
- 09/16/2024
|
DirecTV-Disney Reach Deal That Ends ESPN, ABC Blackout
- The agreement comes just in time to let DirecTV customers check out Sunday's Emmy Awards, and Monday Night Football.
- 09/14/2024
|
DirecTV rejects Disney offer to restore ABC for presidential debate
- DirecTV has rejected Walt Disney Co's offer to restore the ABC network to subscribers to watch Tuesday's U.S. presidential debate, which ABC News is hosting.
- 09/10/2024
|
DirecTV and Disney's public squabble intensifies as Monday Night Football is set to air on ESPN and ABC
- Just before the start of Monday Night Football, tensions in the ongoing contract battle between cable provider DirecTV and the Walt Disney Company have ratcheted up another notch, and a resolution is not yet in sight—meaning that millions of Americans may be unable to watch tonight's game.
- 09/09/2024
|
Disney Pulls ESPN, ABC and More Channels From DirecTV. Everything You Need to Know
- The contract dispute could prevent DirecTV subscribers from watching US Open tennis or Monday Night Football.
- 09/03/2024
|
ESPN networks, ABC and Disney channels go dark on DirecTV
- CNBC's Julia Boorstin joins 'Power Lunch' with details about the contract dispute between Disney and DirecTV.
- 09/03/2024
|
DirecTV Users Lose Access to Disney Networks Including ESPN and ABC
- More than 11 million DirecTV subscribers lost access Sunday afternoon to channels owned by Disney DIS 0.63%increase; green up pointing triangle, including ESPN and ABC, as the satellite broadcaster and entertainment giant were unable to come to terms on a new distribution deal.
- 09/01/2024
|
Disney names veteran producer Almin Karamehmedovic president of ABC News
- Walt Disney has named veteran producer Almin Karamehmedovic as president of ABC News, the television network said on Monday.
- 08/19/2024
|
KNXV-ABC15 honored with Sigma Delta Chi Award from Society of Professional Journalists
- PHOENIX , July 11, 2024 /PRNewswire/ -- The Society of Professional Journalists has awarded KNXV-ABC15, the Phoenix-based local television station owned by The E.W. Scripps Company (NASDAQ: SSP), with a national 2023 Sigma Delta Chi Award for excellence in journalism.
- 07/11/2024
|
AmerisourceBergen Specialty Group Substitute Notice of Data Incident to Affected Individuals
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Specialty Group (ABSG) is issuing a substitute notice to individuals who may have been impacted by a data security incident. ABSG's parent company previously announced the data security incident, which is fully contained. An investigation with the assistance of law enforcement, cybersecurity experts, and outside lawyers has now identified certain individuals whose personal information was involved in the incident. ABSG maintained this inform.
- 06/04/2024
|
AmerisourceBergen Specialty Group Provides Substitute Notice of Data Incident to Affected Individuals
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Specialty Group, LLC (ABSG) is issuing notice to individuals who may have been impacted by a data security incident. ABSG's parent company previously announced the data security incident, which is fully contained. Through an investigation with the assistance of law enforcement, cybersecurity experts and outside lawyers, ABSG has now identified certain individuals whose personal information was involved in the incident. This information was m.
- 05/24/2024
|
Will RFK Jr. Debate Trump or Biden? Probably Not, Prediction Market Says
- This week in prediction markets…Will there be a Biden-Trump-Kennedy debate?When will OpenAI's Sora launch?It's gone to the catsSolana vs. Ethereum: Which chain will earn more in fees?A presidential debate that includes independent candidate Robert F. Kennedy Jr. alongside President Biden or Republican frontrunner Donald Trump is unlikely to happen, bettors on crypto-based predictions platform Polymarket are signaling."Yes" shares in the contract are trading at 27 cents, meaning the market sees a 27% chance of it occurring. Each share pays out $1 if the prediction comes true, and zero if not.The machinations of the American political-industrial complex make it difficult for a third party, or independent candidate, to succeed. Ballot access laws favor major parties, creating significant barriers for third-party candidates. Getting on a debate stage has another high threshold of its own.Rules for the first debate, scheduled for June 27 on CNN, say that the candidates must appear on enough state ballots to hypothetically reach 270 electoral votes, and also receive 15% in four polls. A second debate on ABC is scheduled for September, and it also has a 15% polling rule.Currently, RFK Jr. is polling at just under 10% in national polls compiled by 270toWin. Right now his team says they have confirmed ballot access, or are working on it, in enough states to win 201 electoral votes, which is enough to be a spoiler, but not to win the presidency.But independent candidates have participated in the debates in living memory: in 1992, independent candidate H. Ross Perot appeared on stage alongside George H.W. Bush and Bill Clinton.To be clear, the Polymarket contract says that RFK Jr. must participate in a debate including Trump or Biden. It doesn't say that the debate must be an official one.Trump's campaign wants more debates, according to reports, proposing one per month from June to September, preferring two-hour stand-up debates in larger venues with live audiences.The current train of thought holds that RFK Jr.'s campaign is more of a threat to Biden than Trump's, and polls that include him give Trump a slight edge, up to 5 points in some.It's plausible that the Trump campaign could decide to host a streaming debate with the Kennedy campaign, or hold it on a lesser-known network like OANN. It just needs to be a "publicly broadcast debate" per Polymarket's rules.(Don't forget that Kennedy is coming to CoinDesk's Consensus conference, taking the stage on May 31 at 4:30 PM)When Will OpenAI's Sora Launch?Sora, OpenAI's text-to-video generator, wowed the world when Sam Altman's company demoed the project back in February.Missing is a launch date.Bettors on Kalshi, a U.S.-regulated platform, are predicting that launch will take place sometime between September and the end of 2025, with only a 27% chance it will occur before September.But there's one thing that's getting in the way of a wide release of Sora: the availability of high-end graphics processing units (GPUs). Rendering video from text prompts is going to take a lot of them, more, in fact, than many of the world's largest customers of Nvidia have in their data centers.According to a report by Factorial Funds, OpenAI's Sora faces significant challenges regarding GPU availability, as mainstream adoption of text-to-video generation would require hundreds of thousands of server-grade GPUs at a cost of tens of billions.Factorial estimates that supporting the creator community of platforms like TikTok and YouTube alone would necessitate around 720,000 Nvidia H100 GPUs, far exceeding the combined resources of major tech companies like Microsoft, Meta, and Google.But remember, the contract isn't asking if Sora will be widely available. A launch with limited availability and a high monthly cost would still count. It's just asking if it will launch.Pick of the LitterPunters on Polymarket aren’t expecting any of the best-known cat meme coins to become the first such token to reach the $1 billion market cap milestone.A market capitalization bet for cat-themed tokens, which some expect to flip their dog-themed counterparts in the next bull cycle, has racked up $1.2 million in bets since going live in March. As of Monday, popular tokens Popcat (POPCAT) and cat in a dogs world (MEW) have 22% and 7% odds, while shark cat (SC) and toshi (TOSHI) have odds of under 2%.Despite all these memes being valued at over $200 million and occupying massive mindshare in the meme coin community, punters aren’t expecting any of these to become the first billion-dollar cat meme.Instead, the “others/none in 2024” category dominates the odds at 68%. Other cat-themed tokens in the open market but not referenced in the Polymarket contract are mog (MOG), wen (WEN) and maneki (MANEKI), according to CoinGecko.The high odds for two distinct outcomes suggest traders either expect a whole other cat meme to become the biggest or expect no single token in the category to get such a rich valuation.The apparent bearish sentiment is likely not due to the lack of buying pressure, either. Two dog tokens, bonk (BONK), dogwifhat (WIF), and the frog-themed pepe (PEPE), were launched in 2023 and zoomed to over $3 billion each in less than a year, showcasing the demand for such tokens.Among meme coin hunters, the perceived cuteness of a meme drives its virality and, ultimately, price. So which is cuter: a dog with a pink beanie hat or a cat with a mouth that pops? The punters have decided.Pump.Fun Exploit's ripple effectA market betting on Solana fees flipping those of Ethereum has fallen 12 points in the past week, after jumping up to 35% earlier in the month.The “Solana flips ETH in daily fees in May?” market, which has seen over $60,000 in wagers placed, is a market on whether the daily fees of Solana (SOL) will surpass that of Ethereum (ETH) for any day within this market’s time frame from May 10 to May 31.Odds of the flip rose earlier this month due to a revival of meme coin trading as GameStop stock prices surged higher, aiding growth in meme tokens.However, the odds fell following a $2 million exploit on Pump.Fun, a tool that lets anyone deploy a tradeable token on Solana. The brief exploit may have been expected by some to slow the rapid issuance of meme coins on Solana, which would in turn depress daily fees.Despite being extremely cheap compared to Ethereum, the Solana blockchain collects millions of dollars in fees every day thanks to the sheer magnitude of meme coin trading activity on the network.Still, the fee difference isn’t a big one. Blockchain activity on Ethereum netted it over $1.84 million in the past 24 hours, while it was nearly $1.2 million for Solana, DefiLlama data shows.Pump.Fun has since come back online, and is seeing thousands of new memes launched daily as usual. Peruse it at your risk.Edited by Marc Hochstein.
- 05/20/2024
|
Disney Is or Is Not Selling ABC, Arm IPO Left $1 Billion on the Table, UAW Walks the Talk
- On Monday, the Walt Disney Co. (NYSE: DIS) settled its dispute with Charter Communications Inc.
- 09/15/2023
|
Disney Holds Talks To Sell ABC To Nexstar Media, Report Says
- Discussions are reportedly still preliminary, but Disney CEO Bob Iger has suggested traditional television “may not be core to Disney.”
- 09/14/2023
|
Disney Said to Hold Talks About Selling ABC to Nexstar
- Walt Disney Co. has held exploratory talks about selling its ABC network and TV stations to local broadcaster Nexstar Media Group Inc., according to people familiar with the discussions. Chris Palmeri has more on "Bloomberg Markets: The Close.
- 09/14/2023
|
Disney reportedly in talks with local TV station owner Nexstar to sell ABC
- Disney CEO Bob Iger said in July that the company could sell some of its traditional TV assets that have struggled for years due to the rise of streaming services.
- 09/14/2023
|
Disney stock rises on report it's in early talks with Nexstar on possible sale of ABC
- Walt Disney Co. DIS, +1.11% is in initial talks on a possible sale of ABC to local broadcaster Nexstar Media Group Inc. NXST, +5.27%, Bloomberg News reported, citing people familiar with the situation. The talks are preliminary and no specific valuation has yet been discussed, the people said.
- 09/14/2023
|
Disney, Charter Reach Deal to Restore ESPN, ABC to Spectrum Customers
- Just in time for Monday Night Football, the Walt Disney Company (DIS) will return its content to customers of Charter Communications' Spectrum cable video service, ending a 10-day standoff that saw impacted viewers lose access to ESPN and other Disney channels.
- 09/11/2023
|
Disney and Spectrum Deal Restores ESPN, ABC for Millions of Viewers
- The deal comes just in time for Monday Night Football on ESPN.
- 09/11/2023
|
Charter Fires Shot Heard ‘Round Hollywood With ESPN, ABC Blackout Fight
- Disney's Charter blackout isn't a typical fight over how much more Charter will pay to carry ESPN and ABC. It's the first shot in a fundamental reshaping of cable TV.
- 09/01/2023
|
Disney pulls ESPN, ABC channels from Charter Spectrum
- Disney (DIS) pulled its channels, including ESPN and ABC, from Spectrum's broadcast services after a disagreement over contract fees. Spectrum is owned by Charter Communications (CHTR), the second-largest U.S. cable provider.
- 09/01/2023
|
AmerisourceBergen becomes Cencora, in alignment with the company's growing global footprint and central role in pharmaceutical access and care
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen becomes Cencora, in alignment with the company's growing global footprint and central role in pharmaceutical access and care.
- 08/30/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 08/29/2023
|
AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors has elected Werner Baumann and Lauren M. Tyler as new independent directors, effective October 1, 2023. With the election of Mr. Baumann and Ms. Tyler, the Board of Directors will increase from ten to twelve members, ten of whom are independent. “We look forward to welcoming Mr. Baumann and Ms. Tyler to AmerisourceBergen's Board of Directors. Their experience at preeminent m.
- 08/15/2023
|
Walgreens Sells AmerisourceBergen Shares To Raise $1.85 Billion To Pay Down Debt And Accelerate Health Strategy
- Walgreens Boots Alliance has sold shares of AmerisourceBergen for initial proceeds of $2.85 billion, which will be used to accelerate the drugstore giant's healthcare strategy.
- 08/03/2023
|
Walgreens sells $1.85 bln of AmerisourceBergen shares, further cutting stake
- Walgreens Boots Alliance has sold some AmerisourceBergen Corp's shares for proceeds of about $1.85 billion, the U.S. drugstore chain said on Thursday, further cutting its ownership in the drug distributor to about 16%.
- 08/03/2023
|
Walgreens Boots Alliance sells shares of AmerisourceBergen for $1.85 billion
- Drugstore chain Walgreens Boots Alliance Inc. WBA, -1.17% on Thursday said it sold shares of drug distributor AmerisourceBergen Corp. ABC, -0.04% for initial proceeds of $1.85 billion. Walgreens said it planned to use the proceeds it got from the deal largely to pay down debt and to handle general operations.
- 08/03/2023
|
Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds
- DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance sells shares of AmerisourceBergen Corporation for $1.85 billion of initial proceeds.
- 08/03/2023
|
AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) (the “Company”) announced today a registered public offering of 10.5 million shares of common stock of the Company in connection with Walgreens Boots Alliance Holdings LLC (the “Selling Stockholder”) entering into prepaid variable share forward transactions (the “variable forward transactions”) relating to the Company's common stock with certain counterparties (the “counterparties”). The Company has been advised that,.
- 08/03/2023
|
AmerisourceBergen Corporation (ABC) Q3 2023 Earnings Call Transcript
- AmerisourceBergen Corporation (NYSE:ABC ) Q3 2023 Earnings Call Transcript August 2, 2023 8:30 AM ET Company Participants Bennett Murphy - SVP, Head of IR and Treasury Steve Collis - Chairman, President and CEO Jim Cleary - EVP and CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Lisa Gill - JP Morgan Eric Percher - Nephron Research Daniel Grosslight - Citi Charles Rhyee - TD Cowen Kevin Caliendo - UBS Eric Coldwell - Baird Jonathan Young - Credit Suisse Dan Clark - Bank of America George Hill - Deutsche Bank Operator Hello, and welcome to today's AmerisourceBergen Q3 Fiscal ‘23 Earnings Call. My name is Jordan, and I'll be coordinating your call today.
- 08/02/2023
|
AmerisourceBergen (ABC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
- Although the revenue and EPS for AmerisourceBergen (ABC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 08/02/2023
|
AmerisourceBergen (ABC) Beats on Q3 Earnings, Ups '23 EPS View
- AmerisourceBergen's (ABC) fiscal third-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.
- 08/02/2023
|
AmerisourceBergen forecasts upbeat annual profit as weight-loss drugs lift results
- Drug distributor AmerisourceBergen raised its full-year profit forecast on Wednesday, as soaring demand for weight-loss drugs and specialty medicines helped soften the blow from a fall in COVID-related drug sales in the third quarter.
- 08/02/2023
|
AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)
- AmerisourceBergen has seen a 3x return on investment in the past 3 years, outperforming the market. I think it's a very solid company in pharma and healthcare distribution. Investing in high-quality companies when they are cheap is crucial for maximizing returns. AmerisourceBergen is a conservative and safe option in the pharma and healthcare industry, but has now reached a valuation of where I would consider it a "HOLD".
- 07/28/2023
|
Is a Beat Likely for AmerisourceBergen (ABC) in Q3 Earnings?
- AmerisourceBergen's (ABC) fiscal third-quarter 2023 results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
- 07/26/2023
|
AmerisourceBergen Corporation (ABC) Soars to 52-Week High, Time to Cash Out?
- AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 07/21/2023
|
Hunting for Growth Mixed with Value: Buy These 3 Stocks Now
- Looking at three highly-ranked Zacks stocks that have outperformed the market over the last several years, while posting solid growth. All three stocks we dig into also offer investors great value at the moment.
- 07/20/2023
|
Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report?
- AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/19/2023
|
AmerisourceBergen (ABC) is an Incredible Growth Stock: 3 Reasons Why
- AmerisourceBergen (ABC) could produce exceptional returns because of its solid growth attributes.
- 07/17/2023
|
Is AmerisourceBergen (ABC) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 07/17/2023
|
Is AmerisourceBergen (ABC) Stock Outpacing Its Medical Peers This Year?
- Here is how AmerisourceBergen (ABC) and Hologic (HOLX) have performed compared to their sector so far this year.
- 07/17/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 07/05/2023
|
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2023 on Wednesday, August 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 2, 2023. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executiv.
- 06/29/2023
|
Why Is AmerisourceBergen (ABC) Up 2% Since Last Earnings Report?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
- 06/01/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 05/29/2023
|
Walgreens Sells AmerisourceBergen Shares To Raise $694 Million To Pay Down Debt
- Walgreens Boots Alliance has sold shares of AmerisourceBergen for proceeds of $694 million, which will be used "primarily for debt paydown and general corporate purposes."
- 05/12/2023
|
Should Value Investors Buy AmerisourceBergen (ABC) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/05/2023
|
3 Reasons Growth Investors Will Love AmerisourceBergen (ABC)
- AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 05/04/2023
|
Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Align Technology (ALGN) have performed compared to their sector so far this year.
- 05/03/2023
|
AmerisourceBergen (ABC) Beats on Q2 Earnings, Ups '23 EPS View
- AmerisourceBergen's (ABC) fiscal second-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.
- 05/02/2023
|
AmerisourceBergen (ABC) Beats Q2 Earnings and Revenue Estimates
- AmerisourceBergen (ABC) came out with quarterly earnings of $3.50 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $3.22 per share a year ago.
- 05/02/2023
|
AmerisourceBergen stock pops premarket after earnings blow past estimates
- AmerisourceBergen Corp.'s stock ABC rose 0.8% premarket Tuesday, after the pharmaceutical services company's fiscal second-quarter earnings blew past estimates. The company had net income of $435.4 million, or $2.13 a share, for the quarter to March 31, down from $548.0 million, or $2.59 a share, in the year-earlier period.
- 05/02/2023
|
AmerisourceBergen (ABC) to Post Q2 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal 2023 second-quarter results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.
- 04/26/2023
|
AmerisourceBergen's (ABC) New JV to Boost Oncology Care
- AmerisourceBergen's (ABC) new JV is expected to provide the independent community oncology network with additional resources and expertise to grow the platform and improve patient outcomes.
- 04/21/2023
|
TPG, AmerisourceBergen to OneOncology in a deal that values the oncology practices network at $2.1 billion
- Asset management firm TPG Inc. TPG, +3.12% and pharmaceutical services company AmerisourceBergen Corp. ABC, -1.75% announced Thursday an agreement to buy oncology practices network OneOncology from private equity firm General Atlantic in a deal that values OneOncology at $2.1 billion. After the deal closes, which is expected to occur by the end of September 2023, TPG will own a majority of OneOncology, and AmerisourceBergen will pay $685 million in cash for a 35% stake.
- 04/20/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 04/19/2023
|
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
- Medical stocks are holding up amid economic and market uncertainty. The post 5 S&P 500 Stocks Showing Strength As Recession Fears Rise appeared first on Investor's Business Daily.
- 04/07/2023
|
Magic Formula Dividend Portfolio For April
- The following is a dividend portfolio strategy for large caps that score the highest amongst Joel Greenblatt's Magic Formula screener. The list follows large caps that have dividends.
- 04/07/2023
|
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2023 on Tuesday, May 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 2, 2023. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F.
- 03/29/2023
|
Animal Spirits Are Returning
- This article is an excerpt from the InvestorPlace Digest newsletter. To get news like this delivered straight to your inbox, click here.
- 03/29/2023
|
7 Stocks Set to Soar When the Market Recovers
- While time in the market generally beats out timing the market, it's understandable that some investors may want to hold off on looking for stocks to buy. After all, equities continue to digest the sudden failure of a handful of financial institutions.
- 03/16/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a concern.
- 03/15/2023
|
AmerisourceBergen: A Strong Addition To Any Portfolio
- AmerisourceBergen Corporation is a strong company and leader in the industry it operates within, continuously offering value to shareholders by share buybacks. Revenues came in line with analysts in the last quarter and resulted in the company raising full-year guidance.
- 03/07/2023
|
3 Reasons Why Growth Investors Shouldn't Overlook AmerisourceBergen (ABC)
- AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market.
- 02/27/2023
|
Are Investors Undervaluing AmerisourceBergen (ABC) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/27/2023
|
Dividend Champion, Contender, And Challenger Highlights: Week Of February 19
- A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
- 02/19/2023
|
5 Stocks to Keep an Eye on Following Upgrade by Brokers
- We believe that broker-favorite stocks like Archer Daniels (ADM), Delek US (DK), Beazer Homes (BZH), AmerisourceBergen (ABC) and Avnet (AVT) are worth a look.
- 02/17/2023
|
Is This Warren Buffett Stock a Buy for Dividend Growth Investors?
- This Buffett-backed business leads the medical distribution industry.
- 02/16/2023
|
Should Value Investors Buy AmerisourceBergen (ABC) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/07/2023
|
Dividend Champion, Contender, And Challenger Highlights: Week Of February 5
- A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
- 02/05/2023
|
Here's Why AmerisourceBergen (ABC) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 02/03/2023
|
5 Dental Supplies Stocks to Buy Amid Recovering Prospects
- Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.
- 02/03/2023
|
AmerisourceBergen (ABC) Q1 Earnings Top, EPS View Raised
- AmerisourceBergen's (ABC) fiscal first-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.
- 02/02/2023
|
AmerisourceBergen Corporation (ABC) Q1 2023 Earnings Call Transcript
- AmerisourceBergen Corporation (NYSE:ABC ) Q1 2023 Earnings Conference Call February 1, 2023 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head, Investor Relations & Treasury Steve Collis - Chairman, President, & Chief Executive Officer Jim Cleary - Executive Vice President & Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore Michael Cherny - Bank of America Erin Wright - Morgan Stanley Eric Percher - Nephron Research Charles Rhyee - Cowen George Hill - Deutsche Bank Eric Coldwell - Baird Steven Valiquette - Barclays Brian Tanquilut - Jefferies Operator Hello, everyone, and welcome to the AmerisourceBergen Q1 FY 2023 Earnings Conference Call. My name is Bruno and I will be operating your call today.
- 02/01/2023
|
AmerisourceBergen (ABC) Surpasses Q1 Earnings and Revenue Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 3.44% and 0.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/01/2023
|
AmerisourceBergen Corp. stock rises on Q1 top line beat, raised guidance
- AmerisourceBergen Corp.'s ABC, +2.21% stock rose 0.6% before market open Wednesday after the drug distribution giant reported first-quarter results that beat analysts' revenue expectations and raised its guidance. The company posted net income of $479.8 million, or $2.33 a share, up from $449.1 million, or $2.13 a share in the year-ago period.
- 02/01/2023
|
AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
- 01/27/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 01/25/2023
|
AmerisourceBergen to change name to Cencora later this year
- AmerisourceBergen Corp. ABC, -0.30% said Tuesday it plans to change its name to Cencora in the second half of the year. The drug distribution giant said the new name reflects a “future-oriented mindset.
- 01/24/2023
|
AmerisourceBergen Screams Quality At 15x Earnings, 60% ROIC
- AmerisourceBergen caught a strong bid in the back end of FY22. Diving underneath the hood of its earnings reveals strong evidence of outsized profitability, adding to ABC's ability to create future value for shareholders.
- 01/14/2023
|
Recession Coming? Don't Ask This Hot Fund's Managers
- Want to know what the market will do in 2023? Is a recession coming?
- 01/06/2023
|
Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report?
- AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/04/2023
|
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
- Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
- 01/04/2023
|
AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release
- CONSHOHOCKEN, Pa.--( BUSINESS WIRE )--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2023 on Wednesday, February 1, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on February 1, 2023.
- 01/03/2023
|
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
- Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- 01/02/2023
|
Feds sue drug wholesaler AmerisourceBergen over opioid sales
- HARRISBURG, Pa. — The U.S. Justice Department claimed in a lawsuit filed Thursday that a major drug wholesaler contributed to the deadly toll from opioids by turning a blind eye to warning signs about suspicious sales to its pharmacy customers.
- 12/29/2022
|
Final Trades: American Water, Boeing, Danaher & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 12/28/2022
|
5 Broker-Friendly Stocks to Bank On as Volatility Persists
- Broker-favorite stocks like Cardinal Health (CAH), American Airlines (AAL), Boise Cascade (BCC), AmerisourceBergen (ABC) and Centene (CNC) should be on an investors' watchlist.
- 12/27/2022
|
Buy This Warren Buffett-Owned Stock for 2023 and Beyond
- This healthcare products distributor's business model can withstand a recession.
- 12/26/2022
|
Red-Hot Fund Managers Expect Rocky Start To 2023
- Want to know how to invest in 2023? Red-hot fund manager Dale Harvey says individual investors should fasten their seat belts.
- 12/19/2022
|
Final Trades: UnitedHealth, AmerisourceBergen, Rockwell Automation & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 12/16/2022
|
AmerisourceBergen (ABC) to Repurchase Common Stock Worth $200M
- AmerisourceBergen (ABC) announces a share repurchase worth $200 million in concurrence with the sale of its shares by one of its shareholders, Walgreens Boots Alliance, under Rule 144.
- 12/12/2022
|
This Dividend Aristocrat's High Yield Looks Like a Safe Haven
- Investors shopping for income often begin by asking if a dividend, and particularly a high one, is sustainable. It's a logical and important question every investor should ask.
- 11/29/2022
|
AmerisourceBergen (ABC) Hits 52-Week High: What's Driving It?
- Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.
- 11/28/2022
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 11/22/2022
|
Merck, Nike Among 14 Companies To Announce Annual Dividend Increases In The Second Half Of November
- There were a few double-digit boosts in the first half of November. Most notably, ADP came through with a 20% increase and Snap-On Tools with a 14% increase. Emerson extended its dividend growth streak to 66 years with a 1% boost and Lancaster Colony started its 7th decade of dividend growth with a 6% increase.
- 11/13/2022
|
3 Dental Supplies Stocks to Watch Amid Industry Headwinds
- Here we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors - BDX, MCK and ABC.
- 11/09/2022
|
AmerisourceBergen (ABC) Q4 Earnings & Revenues Top Estimates
- AmerisourceBergen's (ABC) fiscal fourth-quarter 2022 results benefit from segmental growth.
- 11/03/2022
|
AmerisourceBergen Corporation (ABC) Q3 2022 Earnings Call Transcript
- AmerisourceBergen Corporation (NYSE:ABC ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Bennett Murphy - SVP, IR Steven Collis - Chairman, President & CEO James Cleary - EVP & CFO Conference Call Participants Lisa Gill - JPMorgan Chase & Co. Michael Cherny - Bank of America Merrill Lynch George Hill - Deutsche Bank Charles Rhyee - Cowen and Company Eric Percher - Nephron Research Eric Coldwell - Baird Kevin Caliendo - UBS Steven Valiquette - Barclays Bank A.J. Rice - Credit Suisse Operator Ladies and gentlemen, welcome to the AmerisourceBergen Q4 FY 2022 Earnings Call.
- 11/03/2022
|
AmerisourceBergen (ABC) Surpasses Q4 Earnings and Revenue Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 0.78% and 1.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/03/2022
|
AmerisourceBergen profit falls but tops estimates for Q4
- AmerisourceBergen Corp. ABC, -0.97% said Thursday it had net income of $294.7 million, or $1.40 a share, for its fiscal fourth quarter to Sept. 30, down from $437.7 million, or $2.08 a share, in the year-earlier period.
- 11/03/2022
|
The Importance Of Government Contracting For AmerisourceBergen
- AmerisourceBergen has won nearly $1.5bn in government contract awards in 2022 up until the end of Q3. 21.3% Y/Y adjusted EPS growth in Q3 2022 driven by strong operating performance & M&A.
- 11/02/2022
|
AmerisourceBergen (ABC) to Post Q4 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal fourth-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
- 10/25/2022
|
Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report?
- AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/18/2022
|
AmerisourceBergen Corporation: Looking Healthier
- After a few years of stagnation, shares of AmerisourceBergen have come to life again. AmerisourceBergen is seeing solid growth, leverage is low, and opioid settlements have been announced.
- 10/06/2022
|
AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2022 on Thursday, November 3, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 3, 2022. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Exec
- 09/28/2022
|
Outlook Therapeutics enters into commercialization agreement with AmerisourceBergen
- Outlook Therapeutics Inc (NASDAQ:OTLK) said it has entered into a strategic relationship with healthcare company AmerisourceBergen in preparation for the anticipated commercial launch in the United States of its ONS-5010 treatment for wet age-related macular degeneration (AMD). ONS-5010 is an investigational ophthalmic formulation of bevacizumab under development to be administered as an intravitreal injection for the treatment of wet AMD and other retinal diseases.
- 09/27/2022
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 09/26/2022
|
AmerisourceBergen (ABC) to Buy Germany's PharmaLex for $1.3B
- AmerisourceBergen (ABC) inks a deal to acquire PharmaLex to support its goal to become a strategic partner of choice for pharma customers for clinical and commercial enablement solutions.
- 09/13/2022
|
AmerisourceBergen agrees to acquire Germany's PharmaLex for 1.28 billion euros in cash
- AmerisourceBergen Corp. ABC, -0.18% said Monday it has agreed to acquire PharmaLex Holding GmbH, a German company offering specialized services for the life sciences industry, or 1.28 billion euros ($1.29 billion) in cash. The deal "will advance AmerisourceBergen's role as partner of choice for biopharmaceutical manufacturers by enhancing AmerisourceBergen's global portfolio of solutions to support manufacturer partners across the pharmaceutical development and commercialization journey," the company said in a statement.
- 09/12/2022
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 08/24/2022
|
Is WBA Stock A Buy Or Sell After Pivotal Court Ruling In Opioids Case?
- Walgreens faces legal challenges as rising costs eat into profit margins. Is Walgreens stock a buy?
- 08/19/2022
|
Back To The Future With AmerisourceBergen Corporation
- ABC has recently pulled back and provides a potential entry point for investors. Long term, the industry should maintain its 1% share of US expenditure on pharmaceuticals. The Inflation Reduction Act is mainly focused on Medicare Part D. ABC is more heavily exposed to Part B which will be impacted in 2028.
- 08/16/2022
|
Is AmerisourceBergen (ABC) a Solid Growth Stock? 3 Reasons to Think "Yes"
- AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market.
- 08/15/2022
|
Beat the Market the Zacks Way: Walt Disney (DIS), AmerisourceBergen (ABC), C.H. Robinson Worldwide (CHRW) in Focus
- Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week.
- 08/15/2022
|
Has AmerisourceBergen (ABC) Outpaced Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Aerie Pharmaceuticals (AERI) have performed compared to their sector so far this year.
- 08/10/2022
|
Are Investors Undervaluing AmerisourceBergen (ABC) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/10/2022
|
10 defensive stocks that can also provide you with growth and dividends over the long term
- The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.
- 08/10/2022
|
AmerisourceBergen (ABC) Q3 Earnings & Revenues Top Estimates
- AmerisourceBergen's (ABC) fiscal third-quarter results benefit from segmental growth.
- 08/03/2022
|
Amerisourcebergen Corp (ABC) CEO Steven Collis on Q3 2022 Results - Earnings Call Transcript
- Amerisourcebergen Corp (NYSE:ABC ) Q3 2022 Earnings Conference Call August 3, 2022 8:30 AM ET Company Participants Bennett Murphy - SVP, IR Steven Collis - Chairman, President & CEO James Cleary - EVP & CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Lisa Gill - JPMorgan Chase & Co. Eric Percher - Nephron Research A.J. Rice - Crédit Suisse George Hill - Deutsche Bank Steven Valiquette - Barclays Bank Kevin Caliendo - UBS Charles Rhyee - Cowen and Company Operator Hello, everyone, and welcome to the AmerisourceBergen Third Quarter Fiscal 2022 Earnings Call.
- 08/03/2022
|
AmerisourceBergen (ABC) Q3 Earnings and Revenues Surpass Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 1.95% and 1.47%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/03/2022
|
AmerisourceBergen beats profit and revenue expectations, raises full-year outlook
- AmerisourceBergen Corp. ABC, -2.14% reported Wednesday fiscal third-quarter profit and revenue that beat expectations and raised its full-year outlook, amid strength in its International Healthcare Solutions (IHS) business. Shares of the pharmaceuticals and healthcare products company were still inactive in premarket trading.
- 08/03/2022
|
Is a Beat Likely for AmerisourceBergen (ABC) in Q3 Earnings?
- AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
- 07/27/2022
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 07/12/2022
|
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2022 on Wednesday, August 3, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 3, 2022. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executiv
- 06/29/2022
|
Why AmerisourceBergen Is The Best-In-Class Pharmaceuticals Distributor
- AmerisourceBergen is one of the "big three" distributors of pharmaceuticals in the United States. In terms of 2021 revenues, it is almost as big as McKesson. The business is recession-resistant, and because it has high barriers to entry due to its heavy regulation and sophisticated distribution networks. AmerisourceBergen and its peers have an economic moat.
- 06/16/2022
|
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 06/07/2022
|
Why Is AmerisourceBergen (ABC) Down 4.5% Since Last Earnings Report?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
- 06/03/2022
|
AmerisourceBergen sets $1 billion stock buyback program
- AmerisourceBergen Corp. ABC, -1.32% said Wednesday that it set a new $1 billion stock repurchase program. That represents 3.1% of the pharmaceutical and health care products company's market capitalization of $32.42 billion at Tuesday's stock closing price.
- 06/01/2022
|
AmerisourceBergen: A Healthy, Wealthy Stock You Can Count On
- AmerisourceBergen is a leading global drug distributor with a strong focus on operational excellence. The company has recently resolved the majority of its legal troubles related to the Opioid crisis, and is now free to continue growing its business.
- 05/30/2022
|
AmerisourceBergen's stock tanks after largest investor sells $900 million worth of shares
- Shares of AmerisourceBergen Corp. suffered the biggest selloff in more than two years on Thursday, after the drug products and distribution company's largest investor sold off a chunk of its stake.
- 05/12/2022
|
What's Going On With AmerisourceBergen Shares Today
- Walgreens Boots Alliance Inc (NASDAQ: WBA) has sold 6.0 million shares of AmerisourceBergen Corp (NYSE: ABC) at $150 per share. After the sale, Walgreens Boots Alliance's ownership of AmerisourceBergen's common stock decreased from approximately 28.1% to 25.2%.
- 05/12/2022
|
AmerisourceBergen (ABC) Q2 Earnings & Revenues Top Estimates
- AmerisourceBergen's (ABC) fiscal second-quarter results benefit from segmental growth.
- 05/04/2022
|
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q2 2022 Results - Earnings Call Transcript
- AmerisourceBergen Corporation (NYSE:ABC ) Q2 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President-Investor Relations Steve Collis - Chairman, President & Chief Executive Officer Jim Cleary - Executive Vice President & Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore Lisa Gill - JPMorgan Charles Rhyee - Cowen Steven Valiquette - Barclays Eric Percher - Nephron Research Eric Coldwell - Baird George Hill - Deutsche Bank Michael Cherny - Bank of America Operator Good morning or good afternoon all. Welcome to the AmerisourceBergen Corporation Fiscal 2022 Second Quarter Earnings Call.
- 05/04/2022
|
AmerisourceBergen (ABC) Tops Q2 Earnings and Revenue Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 7.69% and 0.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/04/2022
|
AmerisourceBergen beats earnings expectations, and lifts full-year guidance
- AmerisourceBergen Corp. ABC, +1.20% reported first-quarter profit and revenue that rose above expectations, amid strength in international healthcare business, and raised its full-year outlook. The health care services company's stock was still inactive in premarket trading.
- 05/04/2022
|
AmerisourceBergen (ABC) Reports Next Week: Wall Street Expects Earnings Growth
- AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/27/2022
|
AmerisourceBergen's (ABC) Venture Capital Fund to Aid Healthcare
- AmerisourceBergen's (ABC) new corporate venture capital fund to help emerging healthcare startup companies change healthcare for people and animals globally.
- 04/11/2022
|
10 Stocks That Have Moved Over 20% Since The Indices Lost Over 12%!
- The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
- 04/08/2022
|
This Healthcare ETF Has Compelling Prognosis
- Broadly speaking, the healthcare sector isn't on fire this year, but analysts are increasingly bullish on the group, citing attractive quality and valuation traits, among other factors. While the sector isn't yet ablaze in 2022, some big names in the group are delivering for investors, underscoring the point that quality is a virtue.
- 04/04/2022
|
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 04/04/2022
|
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2022 Earnings Release; Announces 2022 Investor Day
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2022 on Wednesday, May 4, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 4, 2022. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executive Vic
- 03/28/2022
|
3 Healthcare Stocks With Healthy Fundamentals
- These three fundamentally sound companies will protect both your vitals and your financial livelihood for years to come.
- 03/25/2022
|
Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Catalyst Pharmaceutical (CPRX) have performed compared to their sector so far this year.
- 03/16/2022
|
AmerisourceBergen: Supplying The Growing Pharmaceutical Demand
- Even after its outperformance, the stock has 30%-plus upside and could be worth at least $182/share today.
- 03/15/2022
|
U.S. should review drugmakers' opioid settlement tax breaks - House panel
- The U.S. Justice and Treasury Departments should review the tax deductions four drugmakers made related to their $26 billion opioid settlement, the U.S. House Oversight and Reform Committee said in a statement on Monday.
- 03/14/2022
|
AmerisourceBergen (ABC) is an Incredible Growth Stock: 3 Reasons Why
- AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 03/09/2022
|
AmerisourceBergen: Supplying The Growing Pharmaceutical Demand
- This company is well-positioned to benefit from several trends that will drive long-term growth of pharmaceutical sales.
- 03/09/2022
|
AmerisourceBergen (ABC) Hits 52-Week High: What's Aiding It?
- Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.
- 03/07/2022
|
5 Dividend Growth Stocks for Safe and Consistent Income
- J.B. Hunt (JBHT), Archer-Daniels (ADM), NVIDIA (NVDA), Tractor Supply (TSCO) and AmerisourceBergen (ABC) could be compelling picks for investors seeking safe and consistent income.
- 03/07/2022
|
AmerisourceBergen (ABC) Up 5.5% Since Last Earnings Report: Can It Continue?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
- 03/04/2022
|
Here's Why You Should Invest in AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment.
- 03/03/2022
|
Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Celularity, Inc. (CELU) have performed compared to their sector so far this year.
- 02/28/2022
|
AmerisourceBergen - Another All Time High
- 100% technical buy signal.
- 02/19/2022
|
AmerisourceBergen (ABC) is a Great Momentum Stock: Should You Buy?
- Does AmerisourceBergen (ABC) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 02/17/2022
|
3 Reasons Growth Investors Will Love AmerisourceBergen (ABC)
- AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 02/14/2022
|
AmerisourceBergen (ABC) Upgraded to Buy: Here's Why
- AmerisourceBergen (ABC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 02/11/2022
|
The Stock-Picking Puzzle: Putting The Pieces Together
- The Stock-Picking Puzzle: Putting The Pieces Together
- 02/07/2022
|
AmerisourceBergen: A Steady Wealth Compounder You'll Want To Own
- AmerisourceBergen has a durable business model and is seeing revenue and margin growth. It has a strong track record of shareholder returns, and has tailwinds in COVID treatments and vaccines.
- 02/03/2022
|
AmerisourceBergen's (ABC) CEO Steve Collis on Q1 2022 Results - Earnings Call Transcript
- AmerisourceBergen's (ABC) CEO Steve Collis on Q1 2022 Results - Earnings Call Transcript
- 02/02/2022
|
AmerisourceBergen (ABC) Q1 Earnings Lag Estimates, Revenues Beat
- AmerisourceBergen's (ABC) fiscal first-quarter results benefit from segmental growth.
- 02/02/2022
|
AmerisourceBergen Q1 Earnings Beats By A Whisker
- AmerisourceBergen Corp's ABC Q1 FY22 adjusted EPS reached $2.58, up 18.3% Y/Y, marginally beating the consensus of $2.57. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School.
- 02/02/2022
|
AmerisourceBergen (ABC) Misses Q1 Earnings Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of -0.39% and 0.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/02/2022
|
AmerisourceBergen matches consensus for profit and revenue, raises full-year guidance
- AmerisourceBergen Corp. ABC, +1.07% matched consensus estimates for profit and revenue for its fiscal first quarter on Wednesday, and raised its full-year guidance. The Conshocken, Pa.
- 02/02/2022
|
AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
- 01/27/2022
|
AmerisourceBergen (ABC) Reports Next Week: Wall Street Expects Earnings Growth
- AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/26/2022
|
AmerisourceBergen (ABC) is a Top-Ranked Momentum Stock: Should You Buy?
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 01/24/2022
|
7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022
- These seven low-labor-cost stocks -- including Apple and PayPal -- are buys as the U.S. labor market tightens and wages rise in 2022. The post 7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022 appeared first on InvestorPlace.
- 01/21/2022
|
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment. However, stiff competition is a woe.
- 01/11/2022
|
AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2022 on Wednesday, February 2, 2022 prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on February 2, 2022. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Execu
- 01/04/2022
|
AmerisourceBergen (ABC) Hits 52-Week High: What's Aiding It?
- Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.
- 12/27/2021
|
Options Income Series: Earn High Income Safely And Consistently - December 2021
- We explain why selling the cash-covered puts and covered calls is a safer choice and earns a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable.
- 12/25/2021
|
Has AmerisourceBergen (ABC) Outpaced Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
- 12/16/2021
|
Has AmerisourceBergen (ABC) Outpaced Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
- 12/16/2021
|
Here's Why You Should Invest in AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment.
- 12/08/2021
|
Dividend Champions For December 2021
- Monthly update of the Dividend Champions List. 75 companies declared higher dividends in the past month, with an average increase of 8.55% over their previous payouts.
- 12/02/2021
|
McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters
- A Washington state trial against McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) for the U.S. opioid epidemic is slated to kick off today, Reuters reported. Washington Attorney General Bob Ferguson declined to join a $26 billion nationwide settlement and has accused the drug distributors of creating a public nuisance by failing to prevent the diversion of prescription pills into illegal channels.
- 11/15/2021
|
Second Half Of November Brings Dividend Increases From Merck, Nike And 12 Others
- Investors saw a few very good dividend increases in the first half of November, with ADP, Snap-on, and Roper Technologies announcing double-digit boosts, and a massive 29% boost from HP. The second half of November will bring double-digit boosts from a few more companies including Nike, Motorola Solutions, Aflac, and Agilent Technologies.
- 11/15/2021
|
Dividend Increases: October 30-November 5, 2021
- In this article series, we provide a weekly summary of dividend changes. A summary table presents relevant data and key statistics of dividend increases.
- 11/11/2021
|
AmerisourceBergen (ABC) Soars to 52-Week High, Time to Cash Out?
- AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 11/08/2021
|
3 Reasons AmerisourceBergen Is A SWAN Worth Buying Today
- 3 Reasons AmerisourceBergen Is A SWAN Worth Buying Today
- 11/05/2021
|
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 Fiscal 2021 Results - Earnings Call Transcript
- AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 Fiscal 2021 Results - Earnings Call Transcript
- 11/04/2021
|
AmerisourceBergen (ABC) Q4 Earnings and Revenues Surpass Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 1.27% and 3.92%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/04/2021
|
3 Stocks to Buy as the Economy Recovers
- These companies have been delivering strong results, and investors should expect that to continue next year.
- 10/21/2021
|
Here's Why AmerisourceBergen (ABC) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 10/13/2021
|
Here's Why You Should Invest in AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment.
- 10/06/2021
|
Drug Distributors Ink First Opioid Settlement With Cherokee Nation
- Cardinal Health Inc (NYSE: CAH), McKesson Corporation (NYSE: MCK), and AmerisourceBergen Corp (NYSE: ABC), accused of U.S. addiction crisis, have struck a settlement with a tribal government, Reuters reports. As part of the deal with Cherokee Nation's territory in Oklahoma, the three companies will pay $75 million over six and half years to resolve claims linked to the opioid epidemic in the region.
- 09/28/2021
|
AmerisourceBergen Unveils New Global Headquarters in Conshohocken, PA & Announces Great Place to Work® Recognition
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Today, AmerisourceBergen (AB), a global healthcare company, hosted a ribbon cutting ceremony to commemorate the opening of its new global headquarters in Conshohocken, Pa. The 429,000 sq. ft. facility designed by Gensler includes tech-enabled conference and business centers, a fitness center, and dining site services. The new building is part of SORA West -- a multi-faceted complex developed by Keystone Property Group which will include a 127-room boutique ho
- 09/28/2021
|
3 Stock Ideas For An Expensive Market
- With most stock indices near all-time highs and lofty valuations on most mega-cap stocks, it can be difficult to find good long-term values right now in the overall stock market. At the individual stock level, however, there are a few solid values even within the components of the S&P 500 index that aren't cyclical in nature.
- 09/15/2021
|
Here's Why You Should Retain AmerisourceBergen (ABC) Stock Now
- AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment.
- 09/07/2021
|
Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase
- CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that, under the previously announced proposed settlement agreement and process designed to resolve the opioid claims of state and local governmental entities, they have determined that enough states have agreed to settle to proceed to the next phase. Under the proposed settlement agreement and process, all U.S. States, territories
- 09/04/2021
|
Why Is AmerisourceBergen (ABC) Up 2.5% Since Last Earnings Report?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
- 09/03/2021
|
AmerisourceBergen to Participate in Upcoming Investor Conferences
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate virtually in the following upcoming investor conferences: Morgan Stanley 19th Annual Global Healthcare Conference, to be held on September 9-10 & September 13-15, 2021; and Baird 2021 Global Healthcare Conference, to be held on September 14-15, 2021. Please check the website investor.amerisourcebergen.com for updates regarding the timing of live webcasts, if any, and for re
- 09/02/2021
|
AmerisourceBergen: Boring But Beautiful Buy For Your Rich Retirement
- AmerisourceBergen: Boring But Beautiful Buy For Your Rich Retirement
- 08/04/2021
|
AmerisourceBergen Stock Gains As Q3 Earnings Tops Wall Street Estimates; Raises FY21 EPS Guidance
- AmerisourceBergen Corporation's (NYSE: ABC) Q3 for fiscal 2021 reports an adjusted EPS of $2.16, topping the analyst consensus estimate of $2.03. Revenue of $53.4 billion increased 17.7% Y/Y, beating the analyst consensus estimate of $52.05 billion.
- 08/04/2021
|
AmerisourceBergen (ABC) Beats Q3 Earnings and Revenue Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 7.46% and 3.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/04/2021
|
AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 third quarter ended June 30, 2021, revenue increased 17.7 percent year-over-year to $53.4 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $1.40 for the June quarter of fiscal 2021, compared to $1.41 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described bel
- 08/04/2021
|
Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report?
- AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/26/2021
|
US States Get $26B Settlement Deal in Opioid Abuse Litigation
- Attorney generals of several states reach settlement deal with J&J (JNJ) and three drug distributors - MCK, CAH and ABC - related to thousands of opioid abuse litigations. Non-participating states may join the deal soon.
- 07/22/2021
|
States announce $26 billion settlement to resolve opioid lawsuits: RPT
- Chris Meekins, Healthcare Policy Research Analyst at Raymond James, joins Yahoo Finance's Kristin Myers and Alexis Christoforous to discuss healthcare talks in Washington this week and the latest news on the opioid lawsuits.
- 07/21/2021
|
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
- What did the stock market do today? It began to address the opioid crisis, it tuned in on Bitcoin and it saw a devastating Olympics loss.
- 07/21/2021
|
Distributors Announce Proposed Opioid Settlement Agreement
- CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. While the companies strongly dispute the allegations made in these lawsuits, they believe the pr
- 07/21/2021
|
AmerisourceBergen (ABC) Soars 3.5%: Is Further Upside Left in the Stock?
- AmerisourceBergen (ABC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- 07/21/2021
|
Drug distributors settle New York opioid claims for up to $1.18 bln
- NEW YORK, July 20 (Reuters) - The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid epidemic, the state's attorney general said on Tuesday.
- 07/20/2021
|
McKesson, Cardinal Health, AmerisourceBergen stocks surge after $1.1 billion opioid settlement with NY AG
- Shares of McKesson Corp. , Cardinal Health Inc. and AmerisourceBergen Corp. all surged more than 4% in morning trading Tuesday, after the New York Attorney General Letitia James announced a $1.1 billion settlement agreement with the drug distributors to combat the opioid epidemic. James said the agreement resolves claims for the companies' role in helping fuel the epidemic, and will remove the companies from the ongoing opioid trial.
- 07/20/2021
|
MedTech Thrives on Healthcare IT in 2021: 4 Stocks to Focus on
- Health IT stocks like HealthEquity (HQY), Veeva Systems (VEEV), Tabula Rasa (TRHC) and Allscripts (MDRX) are expected to continue their run over the next few months.
- 07/16/2021
|
Why You Shouldn't Bet Against AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- 07/08/2021
|
Here's Why You Should Retain AmerisourceBergen (ABC) Now
- AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment.
- 07/08/2021
|
Brokers' Upgrade Adds to the Attractiveness of These 5 Stocks
- Investors should keep an eye on broker-friendly stocks like Atlas Air (AAWW), Caleres (CAL), AmerisourceBergen (ABC), Chico's FAS (CHS) and Builders FirstSource (BLDR) for impressive returns.
- 07/07/2021
|
New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid
- Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly marketed opioid drugs as having a low addiction risk, a lawyer for a New York county told jurors, urging them to hold the companies liable. Jayne Conroy, representing Suffolk County, also said that the drug distributors - AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and McKesson Corp (NYSE: MCK) failed to report suspicious opioid orders as required.
- 06/29/2021
|
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2021 on Wednesday, August 4, 2021, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 4, 2021. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executiv
- 06/24/2021
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 06/21/2021
|
Overview Of Opportunities In Animal Companionship: A $200B Industry Growing At 6.1% Annually
- The physiological and psychological benefits that pets give us are meaningful. COVID has amplified our appreciation of this. Anticipating 6% annual growth until 2030 may be conservative, even across developed markets.
- 06/11/2021
|
Here's Why You Should Retain AmerisourceBergen (ABC) Now
- AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment.
- 06/09/2021
|
AmerisourceBergen to Participate in Upcoming Investor Conferences
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate virtually in the following upcoming investor conferences: Goldman Sachs 42nd Annual Global Healthcare Conference, to be held on June 8-11, 2021; and Baird Healthcare ESG Symposium, to be held on June 17, 2021. Please check the website investor.amerisourcebergen.com for updates regarding the timing of the live webcasts, if any, and for replay information. About AmerisourceBergen
- 06/04/2021
|
Walgreens Completes $6.5B Sale Of European Distribution Business To AmerisourceBergen
- The large drug wholesaler AmerisourceBergen completed its acquisition of the majority of Walgreens Boots Alliance's “Alliance Healthcare” wholesale distribution business for $6.5 billion.
- 06/02/2021
|
Pharmacy stocks tumble on report Amazon is weighing a push into physical pharmacies (AMZN, CVS, RAD, WAG, CAH, MCK, ABC)
- Shares of drug retailers including Walgreens Boots Alliance and CVS dropped on Wednesday, as Amazon was reported to be looking at options to set up physical pharmacy locations in the US. Talks at Amazon about setting up standalone pharmacies are mostly exploratory and there are no firm plans to open physical locations, three people familiar with the matter told Insider. Such a move would be part of a plan by the online retail behemoth to earn a larger share of the country's $370 billion prescription drug market.
- 05/26/2021
|
AmerisourceBergen: A-Rated Healthcare Blue Chip With 17 Years Of Dividend Growth
- ABC benefits from a very strong balance sheet. ABC has durable competitive advantages.
- 05/22/2021
|
AmerisourceBergen Stock Dives After Q2 Earnings Fall Short Of Expectations
- AmerisourceBergen Corporation (NYSE: ABC) shares dropped after the company's Q2 for fiscal 2021 failed to meet the consensus estimates. It reported an adjusted EPS of $2.53 topped the analyst consensus estimate of $2.48.
- 05/05/2021
|
AmerisourceBergen (ABC) Q2 Earnings Beat, Revenues Miss
- AmerisourceBergen's (ABC) fiscal second-quarter results benefit from segmental growth.
- 05/05/2021
|
AmerisourceBergen (ABC) Q2 Earnings Top Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 0.80% and -1.58%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2021
|
AmerisourceBergen stock falls after profit beats forecasts but revenue was a bit light
- Shares of AmerisourceBergen Corp. fell 0.7% in premarket trading Wednesday, after the pharmaceuticals and health care products company reported a first-quarter profit that beat expectations but revenue that came up a bit light. Net income fell to $435.3 million, or $2.10 a share, from $960.3 million, or $4.64 a share, in the year-ago period.
- 05/05/2021
|
AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent year-over-year to $49.2 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.10 for the March quarter of fiscal 2021, compared to $4.64 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described b
- 05/05/2021
|
Why AmerisourceBergen (ABC) Might Surprise This Earnings Season
- AmerisourceBergen (ABC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 05/04/2021
|
AmerisourceBergen (ABC) to Post Q2 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal second-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
- 04/30/2021
|
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
- 04/21/2021
|
All You Need to Know About AmerisourceBergen (ABC) Rating Upgrade to Buy
- AmerisourceBergen (ABC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 04/08/2021
|
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2021 on Wednesday, May 5, 2021, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 5, 2021. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executive Vic
- 04/01/2021
|
AmerisourceBergen Closes $1,525,000,000 0.737% Senior Notes Due 2023 and $1,000,000,000 2.700% Senior Notes Due 2031
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $1,525,000,000 aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (the “2023 Notes”) and $1,000,000,000 aggregate principal amount of its 2.700% Senior Notes due March 15, 2031 (the “2031 Notes” and, together with the 2023 Notes, the “Notes”), in an underwritten registered public offering. The offering was made pursuant to an effective shelf r
- 03/30/2021
|
AmerisourceBergen (ABC) Hits New 52-Week High: What's Driving It?
- AmerisourceBergen (ABC) is optimistic about maintaining a robust segmental performance amid the pandemic-led business disruptions.
- 03/26/2021
|
AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $1.525 billion aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (the “2023 Notes”) and $1.0 billion aggregate principal amount of its 2.700% Senior Notes due March 15, 2031 (the “2031 Notes” and, together with the 2023 Notes, the “Notes”), in an underwritten registered public offering. The offering is being made pursuant to an effective shelf registration statemen
- 03/25/2021
|
AmerisourceBergen: This SWAN Is Still On Sale, Here's Why
- AmerisourceBergen has underperformed the market, despite strong and steady performance.
- 03/24/2021
|
Building A Dividend Growth Portfolio From Scratch In Today's Expensive Market
- The current valuation suggests that investors purchasing the index today could suffer through negative returns for the next 2 to 3 years or longer. Low interest rates have generated strong demand for dividend growth stocks.
- 03/18/2021
|
3 Stocks to Capitalize on Promising Dental Supplies Industry
- 3 Stocks to Capitalize on Promising Dental Supplies Industry
- 03/10/2021
|
Why Is AmerisourceBergen (ABC) Down 6.3% Since Last Earnings Report?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
- 03/06/2021
|
AmerisourceBergen CEO on how U.S. vaccine distribution is going
- Steve Collis, AmerisourceBergen CEO, joins 'Squawk on the Street' to discuss the role his company has played in the federal retail pharmacy program and his thoughts on the vaccine distribution.
- 03/02/2021
|
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q1 2021 Results - Earnings Call Transcript
- AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q1 2021 Results - Earnings Call Transcript
- 02/04/2021
|
AmerisourceBergen (ABC) Q1 Earnings & Revenues Beat Estimates
- AmerisourceBergen's (ABC) fiscal first-quarter results benefit from segmental growth.
- 02/04/2021
|
AmerisourceBergen (ABC) Q1 Earnings and Revenues Top Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 12.37% and 3.84%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/04/2021
|
AmerisourceBergen's stock surges after profit and revenue beats, raised outlook
- Shares of AmerisourceBergen Corp. rallied 2.9% in premarket trading Thursday, after the pharmaceuticals and health care products development and delivery company reported fiscal first-quarter profit and revenue that beat expectations and raised its full-year outlook. Net income for the quarter to Dec. 31 rose to $374.8 million, or $1.81 a share, from $187.6 million, or 90 cents a share, in the year-ago period.
- 02/04/2021
|
AmerisourceBergen Reports Fiscal 2021 First Quarter Results
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent year-over-year to $52.5 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $1.81 for the December quarter of fiscal 2021, compared to $0.90 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items descri
- 02/04/2021
|
Why AmerisourceBergen (ABC) Might Surprise This Earnings Season
- AmerisourceBergen (ABC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 02/03/2021
|
AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
- 02/01/2021
|
A Trio of Low Price-to-Free-Cash-Flow Ratio Stocks to Consider
- When looking for value opportunities, one method is to choose stocks whose trailing 12-month price-to-free-cash-flow ratios are low compared to that of the S&P 500 index, which stands at 15.28 as of the writing of this article. In my view, these equities are more likely to be selling at a compelling price.
- 01/27/2021
|
Here's Why You Should Retain AmerisourceBergen (ABC) Now
- AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
- 01/25/2021
|
Is AmerisourceBergen (ABC) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/20/2021
|
AmerisourceBergen Announces Quarterly Dividend
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors declared a quarterly dividend of $0.44 per common share, payable March 1, 2021, to stockholders of record at the close of business on February 12, 2021. About AmerisourceBergen AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and lives
- 01/14/2021
|
AmerisourceBergen (ABC), WBA Ink Deal to Focus on Core Arms
- AmerisourceBergen (ABC) and Walgreens (WBA) enter into a key strategic deal to boost focus on core businesses, while extending their partnership.
- 01/07/2021
|
Walgreens to sell its distribution unit to AmerisourceBergen for £4.78 billion
- In an announcement on Wednesday, Walgreens Boots Alliance Inc (NASDAQ: WBA) said it will sell its distribution business to AmerisourceBergen Corp (NYSE: ABC) for £4.78 billion. Walgreens shares were seen more than 2% up in premarket trading on Wednesday and jumped another 2.5% in the next few hours.
- 01/06/2021
|
Walgreens To Sell Wholesale Drug Operation To AmerisourceBergen For $6.5 Billion
- The large drug wholesaler AmerisourceBergen will acquire the majority of Walgreens Boots Alliance's “Alliance Healthcare business” for $6.5 billion, the companies announced Wednesday.
- 01/06/2021
|
Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
- AmerisourceBergen also raised its guidance, sending shares up more than 6% in early Wednesday trade
- 01/06/2021
|
AmerisourceBergen to buy Walgreens' distribution business in $6.5 billion deal
- Drug distributor AmerisourceBergen Corp said on Wednesday it would buy Walgreens Boots Alliance's distribution business, Alliance Healthcare, for $6.5 billion.
- 01/06/2021
|
AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today updated its fiscal year 2021 financial guidance to reflect the Company's continued strong operating income performance. The Company will be participating in upcoming investor discussions in which the updated outlook for fiscal year 2021 will be discussed. This updated financial guidance does not include any contribution from the proposed Alliance Healthcare acquisition or any incremental growth from the expanded
- 01/06/2021
|
AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
- VALLEY FORGE, Pa. & DEERFIELD, Ill.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) and Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced strategic agreements under which AmerisourceBergen will acquire the majority of Walgreens Boots Alliance's Alliance Healthcare businesses for approximately $6.5 billion, comprised of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock. AmerisourceBergen's acquisition of Alliance Healthcare will provide even str
- 01/06/2021
|
AmerisourceBergen Primed For A Bounce
- AmerisourceBergen is a pharmaceutical distribution company that has seen solid earnings and revenue growth. The company does have a deal with the CDC to handle the distribution of COVID vaccines to independent pharmacies.
- 01/05/2021
|
AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2021 Earnings Release and Participation in Upcoming Investor Conferences
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2021 on Thursday, February 4, 2021, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on February 4, 2021. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Execu
- 12/30/2020
|
Here's Why You Should Retain AmerisourceBergen (ABC) Now
- AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
- 12/23/2020
|
When a COVID-19 Vaccine Is Ready, This Company Is Prepared for Action
- One medical distribution company has been through this before.
- 12/08/2020
|
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 2020 Results - Earnings Call Transcript
- AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 2020 Results - Earnings Call Transcript
- 11/05/2020
|
AmerisourceBergen Shares Pop Amid Strong 2020 Growth; Earnings Due As It Gets Closer To Key Technical Measure
- AmerisourceBergen shows rising price performance, earning an upgrade to its IBD Relative Strength Rating. The post AmerisourceBergen Shares Pop Amid Strong 2020 Growth; Earnings Due As It Gets Closer To Key Technical Measure appeared first on Investor's Business Daily.
- 11/04/2020
|
Were These Hedge Funds Right About AmerisourceBergen Corporation (ABC)?
- Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that's why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an individual investor's stock selection process, as it may offer great insights of how the brightest minds of the finance industry feel about specific stocks. After all, these people have access to smartest analysts and expensive data/information sources that individual investors can't match. So should one consider investing in AmerisourceBergen Corporation (NYSE:ABC)? The smart money sentiment can provide an answer to this question.
- 11/02/2020
|
15 High-Yield/Low Volatility Blue Chips For The Ultimate Crash-Proof Retirement Portfolio
- The pandemic is out of control all over the world, with daily records in new cases and a mounting death toll. Europe is beginning to lock down again and IHME expects up to 20 US states to follow suit starting in late November.
- 11/02/2020
|
IBM Retirement Fund Acquires 1,329 Shares of AmerisourceBergen Co. (NYSE:ABC)
- IBM Retirement Fund boosted its holdings in AmerisourceBergen Co. (NYSE:ABC) by 39.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,735 shares of the company’s stock after acquiring an additional 1,329 shares during the period. IBM Retirement Fund’s holdings in AmerisourceBergen […]
- 10/21/2020
|
Campbell & CO Investment Adviser LLC Purchases Shares of 2,851 AmerisourceBergen Co. (NYSE:ABC)
- Campbell & CO Investment Adviser LLC purchased a new stake in shares of AmerisourceBergen Co. (NYSE:ABC) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 2,851 shares of the company’s stock, valued at approximately $276,000. Other institutional investors have also recently bought and sold shares […]
- 10/19/2020
|
Flagship Harbor Advisors LLC Acquires 165 Shares of AmerisourceBergen Co. (NYSE:ABC)
- Flagship Harbor Advisors LLC increased its holdings in shares of AmerisourceBergen Co. (NYSE:ABC) by 27.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 777 shares of the company’s stock after buying an additional 165 shares during the quarter. Flagship Harbor Advisors […]
- 10/19/2020
|
CX Institutional Raises Position in AmerisourceBergen Co. (NYSE:ABC)
- CX Institutional grew its position in shares of AmerisourceBergen Co. (NYSE:ABC) by 44.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 27,023 shares of the company’s stock after buying an additional 8,302 shares during the quarter. CX Institutional’s holdings in AmerisourceBergen […]
- 10/14/2020
|
MWI Animal Health Selects CVP Impack Automated Packaging Solution to Create Greater Warehouse Efficiencies
- MWI Animal Health Selects CVP Impack Automated Packaging Solution to Create Greater Warehouse Efficiencies
- 10/13/2020
|
Global Healthcare Cold Chain Logistics Market Report 2020 with COVID-19 Impact Analysis - Vaccine Segment Expected to Reach $7.1 Billion by 2027 - ResearchAndMarkets.com
|
AmerisourceBergen Corp. (NYSE:ABC) Shares Bought by Carroll Financial Associates Inc.
- Carroll Financial Associates Inc. boosted its stake in shares of AmerisourceBergen Corp. (NYSE:ABC) by 9.5% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 1,316 shares of the company’s stock after acquiring an additional 114 shares during the period. Carroll Financial Associates Inc.’s holdings in AmerisourceBergen were worth […]
- 10/09/2020
|
Owens & Minor: A Treacherous Path To 10% Returns (NYSE:OMI)
- This might be the most treacherous path to double-digit returns that I have yet to see. Since I wrote my original article, the healthcare distribution sector overall faced many challenges that have affected the stock values of the entire sector.
- 10/09/2020
|
ION & IPN Solutions Collaborate with Annexus Health to Offer AssistPoint to Specialty Physician Practices
- Today, ION Solutions and IPN Solutions, both part of AmerisourceBergen, announced a collaboration with Annexus Health to offer AssistPoint to specialt
- 10/05/2020
|
Gilead takes over remdesivir distribution in the U.S.
- Shares of Gilead Sciences Inc. undefined were down 0.3% in trading on Thursday after the drugmaker announced it is now in charge of distributing remdesivir,...
- 10/01/2020
|
AmerisourceBergen Will Soon Be Rewarded For Quietly Growing Profits (NYSE:ABC)
- The current stock market is still expensive by historical standards, but deals do occasionally appear.
- 09/28/2020
|
Global $3.6 Bn Healthcare Supply Chain Management Market to 2026 by Model, Function, Delivery Mode, Component, Technology, End-user, Region & Vendor Landscape - ResearchAndMarkets.com
|
Dividends And Reasonable Price Appreciation: Introducing The 'DARPA' Portfolio
- Focusing exclusively on dividend income can lead to substantial erosion of a portfolio over time if the dividends are high because the companies are stagnant.
- 09/13/2020
|
September 2020 Stocks - Financials, Real Estate, Industrials, IT And Pharma
- The time has come once again to look at what sort of companies you'll want to be buying, this time as we move into September of 2020.
- 09/09/2020
|
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
- Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
- 09/04/2020
|
AmerisourceBergen: The Highest Quality Healthcare Company On Sale
- I decided to take a closer look at and write my first article on AmerisourceBergen, a healthcare company I've held for about 1.5 years.
- 09/04/2020
|
Dividend Champion And Contender Highlights: Week Of August 30
|
Amalgamated Bank Trims Stake in AmerisourceBergen Corp. (NYSE:ABC)
- Amalgamated Bank trimmed its stake in AmerisourceBergen Corp. (NYSE:ABC) by 63.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,097 shares of the company’s stock after selling 16,111 shares during the period. Amalgamated Bank’s holdings in AmerisourceBergen were worth $917,000 at the […]
- 08/25/2020
|
PRESS DIGEST - Wall Street Journal - Aug. 19
|
Drug-Distributor Stocks Rise as Opioid Settlement Looks Closer After Report on More Talks
- A group of state attorneys general are demanding more from Johnson & Johnson and the nation’s top drug distributors to settle the sprawling opioid litigation than the companies agreed to pay last year, according to a Tuesday report in The Wall Street Journal.
- 08/18/2020
|
Healthcare Dashboard For August
- A dashboard with metrics of value, quality and momentum by industries. Value and quality scores relative to historical averages.
- 08/18/2020
|
U.S. states seek $26.4 bln from drug firms in opioid litigation - WSJ
|
WSJ News Exclusive | States Seek $26.4 Billion From Drug Companies in Opioid Litigation
- States are asking for around $26.4 billion from major pharmaceutical industry players to help pay for damage wrought by the opioid crisis, the latest demand in yearslong litigation seeking to hold companies accountable for widespread drug addiction.
- 08/18/2020
|
McKesson (MCK) Gains on Potential Vaccine Role
- Here's why McKesson (MCK) shares shot higher Friday. Trade the stock, along with two other drug distributors, with these tactical ideas.
- 08/17/2020
|
Tracking Seth Klarman's Baupost Group Holdings - Q2 2020 Update
- Seth Klarman’s 13F portfolio value increased from $6.77B to $8.01B this quarter. Baupost Group increased Atara Biotherapeutics while dropping Cheniere Energy.
- 08/15/2020
|
AmerisourceBergen: Is This the Right Combination for Investors?
- Good financial strength and high profitability, but is the price suitable? Continue reading...
- 08/13/2020
|
Dividend Champion And Contender Highlights: Week Of August 9
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.
- 08/08/2020
|
4 Construction and Health Care Companies With High Financial Strength
- Companies trading below Peter Lynch value in sectors with good July job growth Continue reading...
- 08/07/2020
|
Walgreens Boots Alliance, Inc. -- Moody's changes Walgreens outlook to negative; affirms ratings
- Moody's also affirmed Walgreens Boots Alliance's P-2 commercial paper rating. "The disruption caused by the coronavirus pandemic has taken a further toll on Walgreen's already weaker than expected operating performance", Moody's Vice President Mickey Chadha stated.
- 08/07/2020
|
Are Investors Undervaluing AmerisourceBergen Corporation (NYSE:ABC) By 37%?
- How far off is AmerisourceBergen Corporation (NYSE:ABC) from its intrinsic value? Using the most recent financial...
- 08/07/2020
|
AmerisourceBergen earnings and revenue beat estimates
- Steve Collis, AmerisourceBergen CEO, joins Yahoo Finance’s The First Trade with Alexis Christoforous and Brian Sozzi to discuss the company’s third-quarter earnings report, future outlook for the pharmaceutical industry overall including a COVID-19 vaccine and much more.
- 08/06/2020
|
Analysts Offer Insights on Services Companies: Charter Communications (NASDAQ: CHTR), AmerisourceBergen (NYSE: ABC) and Thomson Reuters (NYSE: TRI) - Markets
- Analysts fell to the sidelines weighing in on Charter Communications (CHTR – Research Report), AmerisourceBergen (ABC – Research Report) and
- 08/06/2020
|
August 2020 Stocks - Financials, Real Estate, Industrials, IT And Pharma
- The time has come for us to look at just what sort of companies may be appealing to invest in during August.
- 08/06/2020
|
ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio “Tony” Pera to Board of Directors
- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq:ANIP) today announced the appointments of Jeanne Thoma, President and Chief Executive Offic
- 08/06/2020
|
AmerisourceBergen Corp (ABC) Q3 2020 Earnings Call Transcript
- Good morning, and thank you all for joining us to the conference call to discuss AmerisourceBergen's Fiscal 2020 Third Quarter Results. On today's call, we will be discussing non-GAAP financial measures.
- 08/05/2020
|
Coronavirus update: Global death toll tops 700,000 with 18.5 million confirmed cases and U.S. accounts for more than a quarter
- The number of confirmed deaths across the globe from the coronavirus illness COVID-19 climbed above 700,000 on Wednesday, according to data aggregated by...
- 08/05/2020
|
AmerisourceBergen (ABC) Q3 Earnings & Revenues Top Estimates
- AmerisourceBergen's (ABC) fiscal third-quarter earnings benefit from segmental growth.
- 08/05/2020
|
AmerisourceBergen's Debt Overview
- Over the past three months, shares of AmerisourceBergen Inc. (NYSE: ABC) moved higher by 19.15%. Before we understand the importance of debt, let's look at how much debt AmerisourceBergen has.AmerisourceBergen's Debt Based on AmerisourceBergen's balance sheet as of May 7, 2020, long-term debt is at $3.62 billion and current debt is at $522.81 million, amounting to $4.15 billion in total debt. Adjusted for $3.69 billion in cash-equivalents, the company's net debt is at $453.26 million.To understand the degree of financial leverage a company has, investors look at the debt ratio. Considering AmerisourceBergen's $42.04 billion in total assets, the debt-ratio is at 0.1. Generally speaking, a debt-ratio more than 1 means that a large portion of debt is funded by assets. As the debt-ratio increases, so the does the risk of defaulting on loans, if interest rates were to increase. Different industries have different thresholds of tolerance for debt-ratios. A debt ratio of 40% might be higher for one industry, whereas average for another.Why Debt Is Important Debt is an important factor in the capital structure of a company, and can help it attain growth. Debt usually has a relatively lower financing cost than equity, which makes it an attractive option for executives.However, interest-payment obligations can have an adverse impact on the cash-flow of the company. Equity owners can keep excess profit, generated from the debt capital, when companies use the debt capital for its business operations.See more from Benzinga * AmerisourceBergen: Q3 Earnings Insights * Stocks That Hit 52-Week Highs On Friday * Stocks That Hit 52-Week Highs On Friday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 08/05/2020
|
AmerisourceBergen (ABC) Q3 Earnings and Revenues Surpass Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 17.09% and 1.35%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/05/2020
|
AmerisourceBergen: Q3 Earnings Insights
- Shares of AmerisourceBergen (NYSE:ABC) rose 3.1% in pre-market trading after the company reported Q3 results.Quarterly Results Earnings per share rose 5.11% over the past year to $1.85, which beat the estimate of $1.56.Revenue of $45,367,000,000 higher by 0.28% from the same period last year, which beat the estimate of $44,660,000,000.Guidance The upcoming fiscal year's EPS expected to be between $7.80 and $7.95.Conference Call Details Date: Aug 05, 2020Time: 08:30 AMView more earnings on ABCET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestor.amerisourcebergen.com%2Fpresentations-and-events%2Fdefault.aspx&eventid=2400611&sessionid=1&key=6AE283BC297DACA8011BDE901B09AF02®Tag=&sourcepage=registerRecent Stock Performance Company's 52-week high was at $105.21Company's 52-week low was at $72.06Price action over last quarter: Up 18.86%Company Overview AmerisourceBergen is a leading global third-party logistics provider engaged in wholesale pharmaceutical sourcing and distribution of specialty, brand-name, and generic pharmaceuticals and related services to acute-care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, physician practices, dialysis clinics, and other healthcare customers. By acquiring smaller companies, management has attained the ability to compound sterile preparations, distribute veterinary pharmaceuticals and vaccines, transport biopharmaceuticals, and provide inventory and reimbursement consulting services to providers.See more from Benzinga * Stocks That Hit 52-Week Highs On Friday * Stocks That Hit 52-Week Highs On Friday * Benzinga's Top Upgrades, Downgrades For June 15, 2020(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 08/05/2020
|
AmerisourceBergen's stock surges toward 5-year high after profit and revenue beats, raised outlook
- Shares of AmerisourceBergen Corp. undefined surged 4.8% toward a 5-year high in premarket trading Wednesday, as the pharmaceutical products supplier reported...
- 08/05/2020
|
AmerisourceBergen's stock surges toward 5-year high after profit and revenue beats, raised outlook
- Shares of AmerisourceBergen Corp. surged 4.8% toward a 5-year high in premarket trading Wednesday, as the pharmaceutical products supplier reported fiscal third-quarter earnings that beat expectations and raised its full-year outlook. Net income for the quarter to June 30 fell to $289.4 million, or $1.41 a share, from $302.0 million, or $1.43 a share, in the year-ago period. Excluding non-recurring items, adjusted earnings per share came to $1.85, above the FactSet consensus of $1.58. Revenue rose 0.3% to $45.37 billion, beating the FactSet consensus of $44.64 billion, as pharmaceutical distribution services revenue rose 0.1% to $43.6 billion and other revenue grew 4.4% to $1.8 billion, boosted by growth in its ABCS and World Courier businesses. For fiscal 2020, the company raised its adjusted EPS guidance range to $7.80 to $7.95 from $7.35 to $7.65. Revenue is now expected to grow in the mid-single digit percentage range, compared with previous guidance of low- to mid-single digit growth. The FactSet revenue consensus of $187.5 billion implies 4.4% growth. The stock has soared 23.2% year to date through Tuesday, while the S&P 500 has gained 2.3%.
- 08/05/2020
|
AmerisourceBergen Reports Fiscal 2020 Third Quarter Results
- AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2020 third quarter ended June 30, 2020, revenue increased 0.3 percent year-over-year to $45.4 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $1.41 for the June quarter of fiscal 2020, compared to $1.43 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described below, increased 5.1 percent to $1.85 in the fiscal third quarter.
- 08/05/2020
|
A Peek Into The Markets: US Stock Futures Climb Ahead Of Earnings, Economic Data
- Pre-open movers
U.S. stock futures traded higher in early pre-market trade, after recording gains in the previous session. Investors are awaiting earnings results from CVS Health...
- 08/05/2020
|
Medical Products Stock Earnings on Aug 5: RMD, ABC & More
- Many Medical Product stocks might have succeeded in mitigating coronavirus-led downsides banking on huge market adoption of their COVID-19-related healthcare-support products in the second quarter.
- 08/04/2020
|
AmerisourceBergen (ABC) to Post Q3 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
- 08/03/2020
|
AmerisourceBergen (ABC) Scheduled to Post Earnings on Wednesday
- AmerisourceBergen (NYSE:ABC) is scheduled to be announcing its earnings results before the market opens on Wednesday, August 5th. Analysts expect the company to announce earnings of $1.50 per share for the quarter. AmerisourceBergen has set its FY20 guidance at $7.35-7.65 EPS.Persons that wish to listen to the company’s earnings conference call can do so using […]
- 08/03/2020
|
Disney, T-Mobile, CVS, Activision Blizzard, and Other Stocks for Investors to Watch This Week
- Second-quarter earnings season continues with results from Disney, T-Mobile, Fox, ViacomCBS, and Clorox. Video-game makers Take-Two and Activision Blizzard also report. Plus, July jobs data.
- 08/02/2020
|
Allegiant Flies Above the Pack With Its Budget-Meets-Leisure Formula
- In a year in which airlines have gotten hammered by the pandemic, a carrier with ultralow costs and flexible scheduling takes the lead. Not that the flight may not get a little rough.
- 08/01/2020
|
The jobs report and congressional politics may matter more for markets than earnings in the week ahead
- The market could lose some exuberance as the calendar turns to August, and investors await Friday's July employment report.
- 07/31/2020
|
AmerisourceBergen Corporation : quaterly earnings release | MarketScreener
|
AmerisourceBergen Corporation : publication des résultats trimestriels | Zone bourse
|
10 Biggest Health Care Companies
- With CVS Health in the 1 spot, these are the 10 biggest health care companies by trailing 12-month revenue.
- 07/30/2020
|
Top Stocks for August 2020
- The S&P 500 Index is a market-capitalization-weighted index of the 500 largest publicly traded companies in the U.S. It is widely regarded as the best gauge of large-cap U.S. equities. The S&P 500's total return is 9.5% over the past 12 months. This market performance number and the statistics in the tables below are as of July 29. Here are the top 3 stocks with the best value, the fastest earnings growth, and the most momentum.
- 07/30/2020
|
Analysts Estimate AmerisourceBergen (ABC) to Report a Decline in Earnings: What to Look Out for
- AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/29/2020
|
U.S. judge rejects imposing attorney fee levy on opioid lawsuit settlements
- A federal judge overseeing thousands of opioid lawsuits declined on Monday to grant a demand by plaintiffs attorneys for fees that could be worth billions of dollars, a request drug company defendants had said would jeopardize settlement talks. In February, a committee of plaintiffs attorneys requested that U.S. District Judge Dan Polster in Cleveland order a 7% fee assessment against any settlement. The request could amount to $3.3 billion, based on a $48 billion settlement proposal that five companies including Johnson & Johnson have been negotiating with various state attorneys general.
- 07/27/2020
|
6 Health Care Stocks Trading With Low Price-Sales Ratios
- Walgreens Boots Alliance on the list Continue reading...
- 07/27/2020
|
Coronavirus: Why your local hospital may also need stimulus checks
- One well-known hospital CEO says the government may need to send stimulus to hospitals to help them get through the COVID-19 pandemic.
- 07/23/2020
|
Healthcare Dashboard For July
- A dashboard with metrics of value, quality and momentum by industries. Value and quality scores relative to historical averages.
- 07/21/2020
|
Hanson & Doremus Investment Management Purchases 112 Shares of AmerisourceBergen Corp. (NYSE:ABC)
- Hanson & Doremus Investment Management grew its position in AmerisourceBergen Corp. (NYSE:ABC) by 45.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 360 shares of the company’s stock after purchasing an additional 112 shares during the quarter. Hanson & Doremus Investment Management’s holdings […]
- 07/19/2020
|
AmerisourceBergen (NYSE:ABC) Sets New 52-Week High at $104.70
- AmerisourceBergen Corp. (NYSE:ABC) hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $104.70 and last traded at $104.50, with a volume of 43360 shares changing hands. The stock had previously closed at $102.74. A number of research analysts have recently issued reports on ABC shares. Zacks Investment […]
- 07/19/2020
|
2,250 Shares in AmerisourceBergen Corp. (NYSE:ABC) Acquired by BKD Wealth Advisors LLC
- BKD Wealth Advisors LLC purchased a new position in shares of AmerisourceBergen Corp. (NYSE:ABC) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 2,250 shares of the company’s stock, valued at approximately $227,000. Several other large investors have also recently made changes […]
- 07/18/2020
|
July 2020 Dividend Picks - Real Estate, Industrials, Communications And Pharma
- The time has come for us to look at just what sort of companies may be appealing to invest in during this month.
- 07/16/2020
|
Is AmerisourceBergen (ABC) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 07/15/2020
|
ABC vs. WST: Which Stock Is the Better Value Option?
- ABC vs. WST: Which Stock Is the Better Value Option?
- 07/15/2020
|
AmerisourceBergen: A Value Play With A Resilient Business Model
- AmerisourceBergen is one of the leading drug distributors with a strong balance sheet and a broad customer base.
- 07/15/2020
|
Patriot Financial Group Insurance Agency LLC Acquires 349 Shares of AmerisourceBergen Corp. (NYSE:ABC)
- Patriot Financial Group Insurance Agency LLC lifted its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 65.0% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 886 shares of the company’s stock after acquiring an additional 349 shares during the quarter. Patriot Financial Group Insurance Agency LLC’s […]
- 07/13/2020
|
Walgreens - Too Soft, Cheap But No Triggers
- Walgreens has seen soft third quarter earnings, even as sales are flattish. The shortfall and dramatic performance in the UK illustrates just how much further COVID-19 stress could hurt the company.
- 07/13/2020
|
State of Alaska Department of Revenue Raises Holdings in AmerisourceBergen Corp. (NYSE:ABC)
- State of Alaska Department of Revenue increased its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 1.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 29,114 shares of the company’s stock after purchasing an additional 518 shares during the quarter. State of Alaska Department of Revenue’s […]
- 07/12/2020
|
Envestnet Asset Management Inc. Has $31.41 Million Stock Holdings in AmerisourceBergen Corp. (NYSE:ABC)
- Envestnet Asset Management Inc. increased its holdings in AmerisourceBergen Corp. (NYSE:ABC) by 5.7% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 311,653 shares of the company’s stock after purchasing an additional 16,899 shares during the period. Envestnet Asset Management Inc. owned approximately 0.15% […]
- 07/12/2020
|
Were Hedge Funds Right About AmerisourceBergen Corporation (ABC)?
- How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]
- 07/08/2020
|
Do AmerisourceBergen's (NYSE:ABC) Earnings Warrant Your Attention?
- For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
- 07/08/2020
|
Here Are a Few Sectors and Three Dozen Stocks That Strategists Think Will Rise on a Blue Wave
- Strategists in recent days have been gaming out market implications of a Democratic sweep in November’s elections, with sectors that stand to benefit including infrastructure and green technology.
- 07/07/2020
|
Municipal Employees Retirement System of Michigan Boosts Position in AmerisourceBergen Corp. (NYSE:ABC)
- Municipal Employees Retirement System of Michigan increased its holdings in shares of AmerisourceBergen Corp. (NYSE:ABC) by 424.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,330 shares of the company’s stock after purchasing an additional 9,170 shares during the […]
- 07/07/2020
|
MWI Animal Health Announces New Offerings to Alleviate Financial Burdens of Pet Care
- MWI Animal Health, a part of AmerisourceBergen and a leading distributor of animal health products, today announced two new offerings designed to incr
- 07/06/2020
|
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2020 Earnings Release
- AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter Fiscal 2020 on Wednesday, August 5, 2020, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 5, 2020.
- 07/02/2020
|
US gobbles up nearly all of Gilead Covid-19 drug remdesivir for next 3 months, leaving other nations without
- HHS said it had acquired all the supplies of the drug for July and 90% of supplies for August and September. Many developing countries have access to generic versions, but WTO rules could complicate the ability of wealthy nations to import them.
- 07/02/2020
|
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2020 Earnings Release
- AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter Fiscal 2020 on Wednesday, August
- 07/02/2020
|
US secures almost entire world stock of Covid-19 drug remdesivir
- The Donald Trump administration has secured nearly the entire world stock of antiviral drug remdesivir from US-based Gilead Sciences for the next three months, leaving hardly any stock of the key Covid-19 drug for the rest of the world.
- 07/01/2020
|
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
|
US government buys most of world's supply of COVID-19 drug remdesivir -
- The US government has acquired most of the global supply of Gilead’s COVID-19 drug remdesivir until September as health secretary Alex Azar said that Donald Trump had struck an "amazing deal" with the pharma.
- 07/01/2020
|
The AmerisourceBergen Foundation Hosts Nonprofit Conference to Share Best Practices to Support and Serve Communities Around the Globe
- Last week, the AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization dedicated to supporting health-related cause
- 07/01/2020
|
3 Health Care Companies That Beat the Market in the 1st Half of the Year
- GuruFocus screener identifies top performers amid coronavirus pandemic Continue reading...
- 06/30/2020
|
Top Stocks for July 2020
- The S&P; 500 Index is a market-capitalization-weighted index of the 500 largest publicly traded companies in the U.S. It is widely regarded as the best gauge of large-cap U.S. equities. Some of the largest companies in the index include Microsoft Corp.
- 06/30/2020
|
AmerisourceBergen Corp. (NYSE:ABC) EVP Sells $311,256.06 in Stock
- AmerisourceBergen Corp. (NYSE:ABC) EVP Gina Clark sold 3,098 shares of the company’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $100.47, for a total transaction of $311,256.06. Following the completion of the sale, the executive vice president now directly owns 16,667 shares in the company, valued […]
- 06/30/2020
|
Remdesivir, the first coronavirus drug, gets a price tag
- NEW YORK (NYTIMES) - Remdesivir, the first drug shown to be effective against the coronavirus, will be distributed under an unusual agreement with the federal government that establishes non-negotiable prices and prioritises American patients, health officials announced on Monday (June 29).. Read more at straitstimes.com.
- 06/29/2020
|
HHS: 500,000 courses of Gilead Sciences' remdesivir to be available for sale
- Health officials said Monday that it will receive 500,000 treatment courses of Gilead Sciences Inc.'s undefined remdesivir through September that can then be...
- 06/29/2020
|
Coronavirus Treatment: US Government Secures 500,000 Doses Of Gilead's Remdesivir For Next 3 Months
- The deal represents virtually all of Gilead's production through September.
- 06/29/2020
|
Regeneron Used a Charity to Pay Kickbacks, Justice Department Alleges
- Regeneron hiked the price of its drug Eylea and spurred its sales by using a charitable foundation to cover Medicare patients’ out-of-pocket costs for the pricey drug, according to a civil suit.
- 06/26/2020
|
Walgreens Can Do Without British Chemist Boots - BNN Bloomberg
- Walgreens’s Italian billionaire CEO has a chance to do some deals that would make it easier to take the drugstore company private.
- 06/26/2020
|
Walgreens Can Do Without British Chemist Boots
- (Bloomberg Opinion) -- The colossal buyout of Walgreens Boots Alliance Inc. mooted last year may now look like a fantasy. But the pandemic will create opportunities for Chief Executive Officer Stefano Pessina to do preparatory dealmaking that would make it easier to take the drugstore group private. One option for the Italian billionaire could be to remove the company’s middle name by selling the historic Boots business in the U.K.Attention has recently focused on whether the owner of Walgreens and Duane Reade pharmacies could offload its pharmaceuticals wholesale arm. Drug distribution company AmerisourceBergen Corp. approached it about buying the unit for $6 billion, Reuters reported in May. Coincidentally, Walgreens has a 28% stake in AmerisourceBergen that could be worth a similar amount.But Pessina is unlikely to want to part with the division, which mainly operates under the Alliance Healthcare brand. It’s where he began building his empire more than four decades ago. Whereas Boots, the British high-street retailer that began life selling herbal remedies in Nottingham in 1849, didn’t become part of his company until 2006. That makes the chain, with about 2,500 stores in the U.K., a plausible alternative.True, Boots’s sales and profits have declined over the past three years as it grappled with online competition. But it was one of the few retailers allowed to continue operating in Britain during the pandemic. With the Covid-19 crisis expected to spark a surge in spending on health, a buyer might see some turnaround potential in the asset now.That may help Pessina get a decent valuation for the division, which generates two-thirds of its sales from non-prescription health-care and beauty products. According to the most recent accounts available, Boots U.K. had 6.7 billion pounds ($8.3 billion) of revenue in the year to August 2019. Ebitda fell from 572 million pounds in 2018 to 391 million pounds in 2019, hurt by a 70 million-pound increase in costs from a plan to close 200 stores.Given Boots is a largely defensive brick-and-mortar retailer, a useful valuation benchmark would be the U.K. supermarkets, which are valued at between five and eight times their estimated yearly Ebitda. The extent of Boots’s exposure to higher-margin beauty and personal-care items argues for a top-end valuation. That would imply an enterprise value of about 4.2 billion pounds ($5.2 billion), assuming the business can generate annual Ebitda of about 500 million pounds, with another 30 million pounds from its optician services.Boots also operates stores in Ireland, Norway, the Netherlands and Thailand, and it owns 49% of a hearing-care joint venture with Sonova Holding AG. So depending what is included, the exit price may be higher. The question is who might want to buy Boots. A.S. Watson Holdings Ltd., owner of the British Superdrug chain, would be the obvious acquirer, but a combination of the two would likely be prohibited on competition grounds. The same goes for the U.K. supermarkets, even though Tesco Plc has the scale and its incoming CEO Ken Murphy has been a Walgreens lifer.Maybe private equity would be interested in a second go. In 2007, a year after merging his Alliance Unichem chain with Boots, Pessina took the group private with KKR in a $14 billion deal, then Europe’s biggest-ever buyout. This time, an acquirer would need to believe in the opportunity to tap into demand from consumers prioritizing their health and be willing to invest in modernizing Boots’s stores and reinforcing its online offering.Of course, a sale of Boots would be small compared to a transaction encompassing Walgreens as a whole. But it may be the best deal available to Pessina right now, one that could set the stage for even bigger things another day.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Andrea Felsted is a Bloomberg Opinion columnist covering the consumer and retail industries. She previously worked at the Financial Times.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
- 06/26/2020
|
COVID-19: Significant Shift in Strategy of Rural Clinical and Healthcare Logistics Market - Vendor Analysis and Growth Outlook for 2020-2024: Exclusive Report from Technavio
- The Global Rural Clinical and Healthcare Logistics Market will grow by USD 1.73 bn during 2020-2024
- 06/25/2020
|
Analysts' Opinions Are Mixed on These Services Stocks: Cardinal Health (NYSE: CAH) and Kansas City Southern (NYSE: KSU) - Markets
- Analysts have been eager to weigh in on the Services sector with new ratings on Cardinal Health (CAH – Research
- 06/24/2020
|
Near-Term Outlook Bleak for Medical Dental Supplies Industry
- Near-Term Outlook Bleak for Medical Dental Supplies Industry
- 06/22/2020
|
Detroit Police & Fire sues Tesla, Walmart
|
Wal-Mart Faces Pension-Fund Suits Over Internal Opioid Files - BNN Bloomberg
- Wal-Mart Inc. illegally mishandled opioid painkillers sold through its stores for years, two pension funds contend in lawsuits seeking access to internal records of the world’s second-largest retailer.Media reports and information revealed in a mass of opioid lawsuits in federal court show how Wal-Mart failed to comply with laws mandating monitoring of sales of the highly addictive painkillers, attorneys for the Norfolk County Retirement System and the Police and Fire Retirement System of Detroi
- 06/18/2020
|
Wal-Mart faces pension-fund suits over internal opioid files
- Wal-Mart and several U.S. pharmacy chains face a November trial before a federal jury in Cleveland in which states and municipalities will seek billio...
- 06/18/2020
|
Opioid Deal May Be Sped Up Amid State Shortfalls, Analyst Says - BNN Bloomberg
- Companies tied to the opioid epidemic could see a smaller settlement with U.S. states in return for faster payments as local governments hit by the coronavirus face a fiscal crisis and dwindling tax base, according to Morgan Stanley analysts.
- 06/15/2020
|
11 Defensive Dividend Blue - Chips To Help You Sleep Well At Night During The Next Market Decline
- Market volatility is back, exactly as I've been warning readers about for weeks now. The reality of our 24 to 30 month pandemic induced economic crisis means th
- 06/15/2020
|
Short Interest in AmerisourceBergen Corp. (NYSE:ABC) Declines By 8.0%
- AmerisourceBergen Corp. (NYSE:ABC) was the target of a large decline in short interest in May. As of May 29th, there was short interest totalling 3,820,000 shares, a decline of 8.0% from the May 14th total of 4,150,000 shares. Based on an average trading volume of 1,790,000 shares, the days-to-cover ratio is presently 2.1 days. Approximately […]
- 06/15/2020
|
'The Bachelor' casts its first black male lead as Hollywood responds to anti-racism movement
- In light of recent protests against police brutality following the death of George Floyd, Hollywood is continuing to respond and make big changes in order to help combat systemic racism and aid the Black Lives Matter movement. Yahoo Finance's Alexandra Canal breaks down the latest.
- 06/12/2020
|
Insider Selling: AmerisourceBergen Corp. (NYSE:ABC) CAO Sells 19,386 Shares of Stock
- AmerisourceBergen Corp. (NYSE:ABC) CAO Lazarus Krikorian sold 19,386 shares of AmerisourceBergen stock in a transaction that occurred on Monday, June 8th. The shares were sold at an average price of $99.90, for a total transaction of $1,936,661.40. AmerisourceBergen stock opened at $99.90 on Wednesday. The company has a market cap of $20.81 billion, a PE […]
- 06/10/2020
|
Why Is AmerisourceBergen (ABC) Up 11.5% Since Last Earnings Report?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 06/06/2020
|
Stocks That Hit 52-Week Highs On Friday
|
West Virginia sues Walgreens, Rite-aid over painkillers flood
- Rite-Aid and Walgreens failed to monitor and report suspicious orders of prescription painkillers in West Virginia while inundating their retail pharmacies...
- 06/05/2020
|
Here's Why You Should Retain AmerisourceBergen Stock Now
- Investor confidence is high on AmerisourceBergen (ABC) stock, thanks to solid prospects.
- 06/05/2020
|
June 2020 Dividend Picks From Every Sector - Part 2
- My first portion of this month's dividend picks was released a short time ago. In this article, we follow up the other 5 sectors not yet covered. Market recover
- 06/05/2020
|
Got $1,000? Buy These 3 Medical Distributor Stocks
- The industry's big three -- McKesson (NYSE: MCK), AmerisourceBergen (NYSE: ABC), and Cardinal Health (NYSE: CAH) -- have an advantage of scale that make them great long-term ideas for anyone looking for a solid investment. McKesson has raised its quarterly dividend for seven consecutive years, bumping its quarterly payout 5% this year to reach $0.41 per share. It has a 1% yield -- less than the S&P; average of about 2%, but still solid -- and a conservative 11% payout ratio over the trailing 12 months (TTM).
- 06/05/2020
|
West Virginia sues Rite-Aid, Walgreens over pain pill flood
- West Virginia's attorney general has filed a lawsuit accusing Rite-Aid and Walgreens of failing to monitor and report suspicious orders of prescription painkillers
- 06/04/2020
|
Cardinal Health Is Wealth: A Mission-Critical Business On Sale (NYSE:CAH)
- Cardinal Health has a recession-resistant business and is providing essential goods to front-line medical staff. Solid quarterly performance and continued delev
- 06/04/2020
|
Edited Transcript of ABC earnings conference call or presentation 7-May-20 12:30pm GMT
- Q2 2020 AmerisourceBergen Corp Earnings Call
- 06/04/2020
|
Stocks That Hit 52-Week Highs On Wednesday
|
McKesson: Poised To Thrive With Double-Digit Annual Returns (NYSE:MCK)
- McKesson is the largest of the 3 drug distributors and has entrenched relationships with healthcare providers. During the pandemic, its recession-resistant busi
- 06/01/2020
|
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q1 2020 Update
- Glenview Capital Management’s 13F portfolio value decreased around two-thirds from $11.42B to $3.68B this quarter. The number of positions decreased from 50 to
- 06/01/2020
|
Hedge Funds Are Nibbling On AmerisourceBergen Corporation (ABC)
- In this article we will check out the progression of hedge fund sentiment towards AmerisourceBergen Corporation (NYSE:ABC) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and 20 […]
- 05/30/2020
|
Top Stocks for June 2020
- NRG Energy Inc.: NRG Energy is an integrated power company that produces, sells, and distributes energy and provides energy services in the U.S. NRG reported a 75% decline in net income on a 7% drop in revenue in Q1 2020, which ended March 31, 2020. Vornado Realty Trust: Vornado Realty Trust is a real estate investment trust (REIT) that owns office, retail, merchandise mart properties, and other real estate and related investments. The company reported a 48% decline in funds from operations (FFO) per diluted share for Q1 2020, which ended March 31, 2020.
- 05/29/2020
|
Why Big Pharma Is Betting on Blockchain
- The pandemic has exposed major cracks in medical supply chains.
- 05/29/2020
|
Deciphera Prepares To Collect Revenue After First FDA Approval: 'We Are Well-Positioned'
- After 17 years of clinical work, Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) finally has a marketable product. The Food and Drug Administration approved Qinlock as a fourth-...
- 05/29/2020
|
With M&A Hit, Wall Street Bankers Keep Busy With Stock Sales
- (Bloomberg) -- Wall Street bankers are a lot less busy these days, what with the pandemic-induced drop-off in mergers and acquisitions and initial public offerings.But there’s a gritty, less glamorous dealmaking realm that has held up, and it’s helping banks offset some of that lost M&A; and IPO revenue. A variety of companies, looking for liquidity in the weak economy, are selling off big stakes they’ve long held in public corporations.The latest came Monday when French pharmaceutical giant Sanofi launched a $13 billion sale of its 16-year-old, 21% stake in Regeneron Pharmaceuticals Inc. Regeneron, a New York-based biopharmaceutical firm, agreed to buy back about $5 billion of stock while the remaining $7 billion was sold to public investors in the largest public equity offering in the heath-care industry on record, according to data compiled by Bloomberg.Sanofi’s move came a few weeks after the pandemic’s first big deal of this kind, PNC Financial Services Group Inc.’s sale of its quarter-century-old stake of more than $13 billion in BlackRock Inc. The sale was the second-largest equity offering in the U.S. since Alibaba Group Holding Ltd.’s $25 billion IPO in 2014, according to data compiled by Bloomberg.PNC’s BlackRock stake was picked up by existing investors including Wellington Management, Capital Group Cos. and Fidelity Investments, according to people familiar with the matter. At least four state investment vehicles from the Middle East also took part in the offering, the people said.More such sales are coming. SoftBank Group Corp. raised $11.5 billion from transactions related to its stake in Alibaba Group Holding Ltd. which it bought in 2000, and another $2.9 billion capitalizing a 5% stake in its wireless arm. It is also closing in on a deal to sell its roughly 25% T-Mobile US Inc. stake, worth about $20 billion, with a portion being sold to Deutsche Telekom AG, people familiar with the matter have said.These transactions so far account for some of the biggest-ever announced of their kind. All told, there’s been $80.6 billion over 21 secondary offerings announced this year, which beats $53.1 billion over 36 such deals during the same period last year, according to data compiled by Bloomberg.That compares with a 33% drop to $22 billion in volume this year for IPOs in the U.S., the data shows. M&A; activity involving U.S.-based targets plummeted 62% during the same period, sinking to $241 billion, according to the data.For Wall Street, the secondary offerings aren’t as lucrative as other dealmaking but they require less work. Banks usually receive about 1% to 2% of the deal size for advisers fees, compared with 5% to 7% for handling an IPO. But IPOs often involve intensive road shows lasting weeks.Jim Cooney, head of equity capital markets for the Americas at Bank of America Corp., said selling stakes can make sense in the current economy. “The market prefers that companies stick to their core mission and monetize non-strategic assets before selling their own equity,” he said.The offerings mark another way that companies, distressed or not, have been hunting for liquidity since the beginning of the pandemic. Some have drawn down revolving credit lines, sold bonds or new shares and sold stakes to private equity firms. Investors have been willing buyers of shares, attracted by the discounts since shares are marketed at prices below where the stock is trading.These stake sales have investors speculating on what holdings could be unwound next. Here are some sizable ones to watch based on Bloomberg’s data. Bloomberg News isn’t aware of talks about potential sales of these stakes.SoftBank, UberSoftBank is Uber Technologies Inc.’s largest shareholder with a 13% stake worth $7.7 billion. The Japanese conglomerate, led by founder Masayoshi Son, forecasts an operating loss of 1.4 trillion yen ($13 billion) for the fiscal year ended in March after writing down values of the Vision Fund’s investments including WeWork and OneWeb, a satellite operator that filed for bankruptcy.While it isn’t SoftBank’s oldest or most sizable investment, it could help to recoup some losses.Walgreens Boots, AmerisourceBergenWalgreens Boots Alliance Inc. is the largest shareholder in AmerisourceBergen Corp. with a 28% stake, worth about $5.3 billion. AmerisourceBergen recently made an offer to buy the Walgreens pharmaceutical wholesale division, Reuters reported earlier this month.The news had analysts speculating it could be part of a transaction related to Walgreens exiting part of its stake in AmerisourceBergen. The two companies first saw their paths intertwine in 2013 through a $400 million distribution deal that was supposed to last a decade.Nestle, L’OrealSanofi’s deal to sell Regeneron stock also had analysts speculating it could buy back L’Oreal SA’s 9.4% stake in the drug company.That, in turn, raises the possibility that L’Oreal would buy back a 23% stake worth $35.5 billion that Nestle SA holds in the French cosmetics maker. Since this is a 40-year plus relationship, the deal idea has been long pitched by bankers. Over the years, both sides have said that the investment is long-term.HKEx, Kweichow MoutaiHong Kong Exchanges & Clearing Ltd., owner of the Hong Kong Stock Exchange, has a 8.5% stake worth $20 billion in distiller Kweichow Moutai Co.Kweichow Moutai has become a favorite stock in mainland China, and is up 15% this year, while the Shanghai Shenzhen CSI 300 Index fell 6.7%. Cashing out could help fuel HKEx’s ambitions as a dealmaker. It made a surprise bid for the London Stock Exchange last year.Mondelez, Dr PepperMondelez International Inc., the maker of Oreo cookies and Triscuit crackers, holds about about 13% of Keurig Dr Pepper, following a deal in 2018 when Keurig took control of the soda maker. In early March, right as the pandemic led to lockdowns in North America, Mondelez, and another investor connected to JAB Holdings BV called Maple Holdings BV,sold a $1.1 billion stake in Dr Pepper.The broader question for investors is whether Mondelez could sell more of its shares, Bank of America analyst Bryan Spillane said at the time. Mondelez could tap its equity stakes as a source of liquidity to fund acquisitions, he said.Coke, MonsterThe Coca-Cola Co. owns more than 18% of Monster Beverage Corp.’s stock, making it the Corona, California-based company’s largest shareholder, and Monster also uses Coke’s distribution network. While Coke took the minority stake back in 2014 in a push to capitalize on promising new brands, the beverage giant is getting more aggressive with its own offerings, which has sparked tensions with Monster. Analysts have been trying to figure out what Coke’s energy products mean for the future of the partnership.Liberty Broadband, CharterA 26% stake in Charter Communications Inc. has become a crown jewel for John Malone’s Liberty Broadband Corp. which has guided the company on acquisitions since it invested in 2013. But Malone, a savvy dealmaker, has not stopped reshaping his portfolio even in a pandemic and helped pull off a merger of Liberty Global’s U.K. business with Telefonica SA’s earlier this month.(Updates with BlackRock investors in fifth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
- 05/28/2020
|
'Master Thief' behind Ocean's Eleven-style heist fights for freedom
- Sean Murphy, 55, was described by the FBI as one of the best burglars around. Now he is arguing for his freedom, claiming that he has already served his time and should be released.
- 05/28/2020
|
Brink : 'Master Thief' burglar hopes to catch break on sentence | MarketScreener
|
'Master Thief' burglar hopes to catch break on sentence
- COLUMBUS, Ohio (AP) — A self-described “master thief” career criminal is hoping to catch a break on his prison sentence from burglarizing a Brink’s warehouse during which he accidentally set millions of dollars on fire. Sean Murphy and two other men were convicted of breaking into the Brink’s facility in Columbus in January 2009. Murphy received a 20-year sentence in that case, eventually reduced to 13 years on appeal. Before that sentence began, however, he spent a decade in jail awaiting trial for a 2008 Massachusetts burglary during which he stole several New York Giants Super Bowl rings, along with jewels and precious metals. Murphy believes he’s already served the bulk of his federal time and should be out by next year. He notes he was arrested on Jan. 23, 2009, for the Super Bowl ring theft, and finally sentenced for that more than 10 years later, on Dec. 5, 2019. “Everything in between goes toward the federal sentence,” Murphy said in a letter to The Associated Press. Federal prosecutors take a different view. The judge who oversaw the Brink's case said that Murphy's federal sentence is to run on top of any unserved Massachusetts prison term, said Sal Dominguez, an assistant U.S. attorney in Columbus. Murphy, who has yet to formally argue for his release on time served, is awaiting transfer to a Massachusetts prison to serve his time for the Super Bowl ring theft. The 2008 break-in at E.A. Dion Co. in Attleboro, Massachusetts, attracted attention beyond the theft of the Super Bowl rings and the approximately $2.5 million in other goods taken. Murphy and his accomplices' trademark garb of all-black outfits and their access through the roof earned them media mentions as “Ocean's Eleven”-style burglars after the 2001 heist movie. Murphy was in...
- 05/28/2020
|
Shell Asset Management Co. Has $1.02 Million Stake in AmerisourceBergen Corp. (NYSE:ABC)
- Shell Asset Management Co. decreased its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 5.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,551 shares of the company’s stock after selling 700 shares during the period. Shell Asset Management Co.’s […]
- 05/27/2020
|
AmerisourceBergen Selected By Deciphera Pharmaceuticals To Support QINLOCK
|
AmerisourceBergen Selected by Deciphera Pharmaceuticals to Support QINLOCK™
- AmerisourceBergen, a global healthcare solutions leader, announced today that it has been selected by Deciphera Pharmaceuticals (Deciphera) to support QINLOCK (ripretinib). AmerisourceBergen is providing a unified commercialization approach for QINLOCK which was approved by the U.S. Food and Drug Administration (FDA) on Friday, May 15, 2020. QINLOCK is an orally administered kinase switch control inhibitor approved for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
- 05/26/2020
|
AmerisourceBergen Selected by Deciphera Pharmaceuticals to Support QINLOCK™
- AmerisourceBergen, a global healthcare solutions leader, announced today that it has been selected by Deciphera Pharmaceuticals (Deciphera) to support
- 05/26/2020
|
Dividend Champion And Contender Highlights: Week Of May 24
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
- 05/23/2020
|
Top Health Care Stocks for June 2020
- Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as hospitals and health care providers. Health care stocks, as represented by the Health Care Select Sector SPDR ETF (XLV), have outperformed the broader market, providing investors with a total return of 16.3% compared to the S&P; 500's total return of 5.9% over the past 12 months. In 2020, health care stocks have recouped nearly all of their losses since their March plunge while the broader market continues to suffer from the global coronavirus pandemic. The market performance numbers and the statistics in the tables in this story are as of May 20.
- 05/21/2020
|
Shares of several healthcare companies are trading higher in sympathy with the overall market amid strength in oil, strong earnings from Lowe's and optimism towards a US economic rebound.
|
Prescription drug costs would have been a major campaign issue, so what will happen now that coronavirus is center stage?
- (The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
Simon F. Haeder, Pennsylvania State University
(THE CONVERSATION) It's no secret that Americans pay more for prescription drugs than any other developed nation in the world. Per capita spending exceeds US$1,000 a year; the Germans and French pay about half that. For many drugs, prices are dramatically higher than the international average: Dulera, an asthma drug, costs 50 times more, while Januvia, a drug for diabetes, and Combigan, a glaucoma drug, cost about 10 times more.
Politicians on both sides of the aisle have recognized this problem. President Donald Trump has called the situation "wrong" and "unfair"; presumptive Democratic presidential nominee Joe Biden has called to end the "abuse of power" by drug companies while his former competitor Sen. Bernie Sanders has complained about "unfettered capitalism" and "greed."
So why aren't prescription drug prices coming down? As a health policy scholar and political scientist, I believe the roadblock to change is the immense political power wielded by the enormously wealthy - and politically powerful - entities within the pharmaceutical supply chain. For decades, they have been reaping tremendous profits. It is not surprising they are now ready to invest those resources to defend their turf. Their power is and will remain a formidable obstacle to reform. And, coronavirus may have given them an assist by diverting attention away from the problem.
US prescription drug prices: Higher than anywhere
Countless studies have shown that Americans pay much more than other citizens of other development nations for their prescription drugs. This high spending on prescription drugs happens even though it does not use more drugs than other...
- 05/20/2020
|
Global Cosmetic Airless Packaging Market —…—… – Industry Analysis, Segments, Value ...
|
AmerisourceBergen Closes $500 Million Senior Note Offering
- AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $500 million aggregate principal amount of its 2.800% Senior Notes due May 15, 2030 (the "Notes"), in an underwritten registered public offering. The offering was made pursuant to an effective shelf registration statement AmerisourceBergen filed with the Securities and Exchange Commission (the "SEC") on November 20, 2018.
- 05/19/2020
|
These U.S. Companies Are Extremely Undervalued - Part 1
- Normally I focus on only the highest-quality undervalued stocks on the market - in this article, I revisit the concept of the most undervalued stocks on the mar
- 05/19/2020
|
Wolf's Corona Discounts: Bristol-Myers Squibb (NYSE:BMY)
- It's finally time to write about my favorite pharma stock in the corona-discount model. Bristol-Myers Squibb has gone from being a rather insignificant holding
- 05/19/2020
|
AmerisourceBergen Closes $500 Million Senior Note Offering
- AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $500 million aggregate principal amount of its 2.800%
- 05/19/2020
|
Shares of several healthcare companies are trading higher in sympathy with the overall market as optimism around a coronavirus vaccine increased following news from Moderna.
|
Buy Drug Distributors’ Stocks Now, Analyst Says. McKesson and 2 More Potential Winners
- The Covid-19 downturn may be an opportunity for the three big U.S. drug distributors, UBS analyst Kevin Caliende says.
- 05/15/2020
|
UBS Maintains Buy on AmerisourceBergen, Lowers Price Target to $99
|
Oracle Investment Management Inc Buys Agenus Inc, Antares Pharma Inc, Y-mAbs Therapeutics Inc, ...
|
Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C. and Los Angeles County.
|
Eubel Brady & Suttman Asset Management Inc Buys AmerisourceBergen Corp, Steel Dynamics Inc, ...
|
AmerisourceBergen Prices $500 Million 2.800% Senior Notes Due 2030
- AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $500 million aggregate principal amount of its 2.800% Senior Notes due May 15, 2030 (the "Notes"), in an underwritten registered public offering. The offering is being made pursuant to an effective shelf registration statement AmerisourceBergen filed with the Securities and Exchange Commission (the "SEC") on November 20, 2018. The offering is expected to close on May 19, 2020, subject to customary closing conditions. AmerisourceBergen intends to use the net proceeds from the offering to redeem all of its 3.500% Senior Notes due November 15, 2021 and for general corporate purposes.
- 05/12/2020
|
AmerisourceBergen Corporation -- Moody's rates AmerisourceBergen's new senior unsecured bonds at Baa2
- Moody's Investors Service ("Moody's") assigned a Baa2 rating to AmerisourceBergen Corporation's ("AmerisourceBergen") new senior unsecured bonds. Moody's expects that proceeds from the company's new $500 million bond issuance will be used for general corporate purposes, including refinancing activities.
- 05/12/2020
|
AmerisourceBergen Corporation (NYSE:ABC) Passed Our Checks, And It's About To Pay A US$0.42 Dividend
- It looks like AmerisourceBergen Corporation (NYSE:ABC) is about to go ex-dividend in the next 2 days. You can purchase...
- 05/12/2020
|
AmerisourceBergen Prices $500 Million 2.800% Senior Notes Due 2030
- AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $500 million aggregate principal amount of its 2.800% Senior Notes due May 15
- 05/12/2020
|
S&P 500 and Nasdaq Gain on Monday
- Coty shares sink as revenue declined due to pandemic Continue reading...
- 05/11/2020
|
U.S. RESEARCH ROUNDUP-Acushnet Holdings, Equity Residential, Fiserv
- Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Acushnet Holdings, Equity Residential and Fiserv, on
Monday.
HIGHLIGHTS
* Acushnet Holdings Corp : Stephens raises target price to $27 from $24
* Equity Residential : Evercore ISI raises to in-line from underperform
* Fiserv Inc : Keybanc raises target price to $115 from $108
* GTT Communications Inc : SunTrust Robinson cuts to hold from buy
* UDR Inc : Evercore ISI raises to in-line from underperform
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
* Abbvie Inc : SVB Leerink raises price target to $122 from $107
* Accelerate Diagnostics Inc : Piper Sandler cuts target price to $14 from $16
* Acushnet Holdings Corp : Compass Point raises TP to $22.25 from $21.50
* Acushnet Holdings Corp : Keybanc raises target price to $31 from $28
* Acushnet Holdings Corp : Stephens raises target price to $27 from $24
* Advance Auto Parts Inc : UBS raises target price to $140 from $135
* AIG : UBS cuts target price to $45 from $49
* Air Lease Corp : Deutsche Bank cuts target price to $36 from $45
* Air Lease Corp : Stephens raises target price to $36 from $30
* Airgain Inc : Northland Capital Markets raises target price to $23
* Alarm.Com Holdings Inc : Credit Suisse cuts target price to $62 from $64
* Albemarle Corp : RBC raises target price to $66 from $64
* Albemarle Corp : SunTrust Robinson cuts target price to $65 from $90
* Allegiant Travel Co : Evercore ISI cuts target price to $95 from $100
* Allscripts Healthcare Solutions : Canaccord Genuity cuts TP to $11 from $13
* Amdocs Ltd : Citigroup cuts price target to $76 from $83
* Amedisys Inc : Raymond James cuts price target to $210 from $225
* Amedisys Inc : UBS cuts target price to $190 from $208
* American Axle & Manufacturing Holdings : Citigroup raises TP to $7.5 from $6
* American Axle & Manufacturing Holdings : RBC raises target price to $7 from $5
* American Homes 4 Rent : Evercore ISI raises target price to $27 from $25
* Ameriprise Financial Inc : RBC raises target price to $155 from $145
* Amerisourcebergen Corp : Deutsche Bank raises target price to $98 from $93
* Amphastar Pharmaceuticals Inc : BMO raises price target to $21 from $20
* Angi Homeservices Inc : Citigroup raises price target to $10 from $6.5
* Aon Plc : Citigroup cuts price target to $230 from $240
* Aon Plc : KBW raises target price to $192 from $184
* Aon Plc : UBS cuts target price to $197 from $202
* Apache Corp : CFRA cuts to sell from hold; raises price target to $9
* Apache Corp : MKM Partners cuts target price by $1 to $19
* Aptiv Plc : Benchmark cuts price target to $87 from $90
* Arch Capital Group Ltd : UBS cuts target price to $39 from $43
* Atara Biotherapeutics Inc : Jefferies cuts target price to $11 from $13
* Athene Holding Ltd : BMO cuts price target to $60 from $63
* Atricure Inc : BTIG raises target price to $56 from $45
* Atricure Inc : Needham raises target price to $63 from $49
* Atricure Inc : Oppenheimer raises price target to $52 from $45
* Atricure Inc : SVB Leerink raises price target to $55 from $50
* Autonation Inc : CFRA cuts price target by $10 to $50
* Avalonbay Communities Inc : Evercore ISI cuts target price to $181 from $189
* Avista Corp : Guggenheim cuts target price to $38 from $39
* Bain Capital Specialty Finance : Citigroup raises price target to $10 from $7.5
* Ball Corp : Citigroup cuts price target to $86 from $89
* Ball Corp : Northland Capital Markets cuts target price to $80
* Baudax Bio Inc : Oppenheimer cuts price target to $14 from $16
* Bellring Brands Inc : Stifel cuts target price to $23 from $25
* BJ's Restaurants Inc : Deutsche Bank raises target price to $27 from $26
* Bloomin' Brands Inc : BMO raises price target to $10 from $9
* Bloomin' Brands Inc : Deutsche Bank raises target price to $15 from $14
* Bloomin' Brands Inc : Guggenheim raises target price to $15 from $11
* Bloomin' Brands Inc : Raymond James cuts target price to $14 from $15
* BP Midstream Partners LP : Mizuho raises target price to $14 from $13
* Broadridge Financial Solutions : Piper Sandler cuts TP to $120 from $124
* Broadridge Financial Solutions : Rosenblatt Securities ups TP to $115 from $101
* Brookfield Infrastructure Partners LP : BMO raises price target to $46 from $45
* Brookfield Infrastructure Partners LP : Scotiabank cuts Tp to $50 from $51
* Brookfield Property Partners LP : Canaccord Genuity cuts TP to $12 from $13
* Brookfield Property Partners LP : CIBC cuts target price to $18 from $20.50
* Brookfield Property Partners LP : RBC cuts target price to $18 from $22
* Bruker Corp : BTIG cuts price target to $50 from $57
* Cabot Oil & Gas Corp : Tudor Pickering Holt cuts to hold from buy
* Calithera Biosciences Inc : Citigroup raises price target to $10 from $7
* Callaway Golf Co : >: Compass Point cuts target price to $17.50 from $20
* Callaway Golf Co : Compass Point cuts target price to $17.50 from $20
* Camden Property Trust : Evercore ISI cuts target price to $98 from $102
* Camden Property Trust : Stifel raises target price to $96 from $91
* Cardtronics Plc : D.A. Davidson cuts target price to $34 from $40
* Cardtronics Plc : SunTrust Robinson raises target price to $29 from $23
* Cargurus Inc : RBC raises target price to $25 from $22
* Carnival : HSBC raises to buy from hold; cuts target price to $15.9 from $45.3
* Carrier Global Corp : Citigroup raises price target to $20 from $17
* Carvana Co : Oppenheimer raises price target to $127 from $95
* Carvana Co : Oppenheimer raises target price to $127 from $95
* Casella Waste Systems Inc : Jefferies raises target price to $56 from $52
* Casella Waste Systems Inc : Raymond James raises target price to $56 from $49
* Casella Waste Systems Inc : Stifel raises target price to $47 from $45
* Cellectis : Citigroup cuts price target to $15 from $16
* Centurylink Inc : SunTrust Robinson cuts target price to $9 from $10
* Ceridian Hcm Holding Inc : Jefferies raises target price to $65 from $60
* Chevron Corp : Independent Research raises target price to $98 from $90; hold
* CNX Resources Corp : Tudor Pickering Holt cuts to hold from buy
* Cognizant Technology Solutions : Evercore ISI cuts target price to $53 from $55
* Cognizant Technology Solutions Corp : HSBC cuts target price to $56 from $70
* Coherus Biosciences Inc : Citigroup cuts price target to $30 from $31
* Conagra Brands Inc : SunTrust Robinson cuts to hold from buy
* Consolidated Edison Inc : Evercore ISI cuts target price to $85 from $86
* Continental Resources : TD Securities raises target price to $14.50 from $13.50
* Cooper Tire & Rubber Co : JP Morgan cuts target price to $29 from $30
* Corporate Office Properties Trust : SunTrust Robinson raises TP to $28 from $26
* Corteva Inc : RBC raises target price to $31 from $27
* Covanta Holding : Stifel raises to hold from sell; raises TP to $9.50 from $6.50
* Crocs Inc : Piper Sandler raises target price to $28 from $24
* Cross Country Healthcare Inc : BMO cuts price target to $8 from $11
* Cryoport Inc : Stephens raises target price to $23 from $21
* CVR Energy Inc : Credit Suisse raises target price to $19 from $16
* Cytomx Therapeutics Inc : Wedbush raises target price to $16 from $11
* Danaher Corp : Evercore ISI raises target price to $175 from $150
* Danaher Corp : RBC raises target price to $173 from $159
* Datadog Inc : RBC raises target price to $50 from $43
* Dentsply Sirona : Barrington Research cuts to market perform from outperform
* Dentsply Sirona Inc : UBS cuts target price to $44 from $59
* Dicerna Pharmaceuticals : SunTrust Robinson raises target price to $33 from $28
* Diebold Nixdorf Inc : JP Morgan raises target price to $7 from $6
* Diebold Nixdorf Inc : JP Morgan raises to neutral from underweight
* Discovery Inc : Rosenblatt Securities cuts price target to $24 from $27
* Dish Network Corp : RBC cuts target price to $32 from $39
* Domtar : D.A. Davidson cuts to neutral from buy; cuts TP to $26 from $44
* Domtar Corp : Scotiabank cuts target price to $29 from $30
* Domtar Corp : TD Securities raises target price to $26 from $22
* E. W. Scripps Co : Benchmark cuts target price to $15 from $24
* E. W. Scripps Co : Guggenheim raises target price to $8 from $6.50
* Edison Intl.
- 05/11/2020
|
Deutsche Bank Maintains Hold on AmerisourceBergen, Raises Price Target to $98
|
14 questions for Fauci, Redfield, and the other Trump officials on Covid-19
- Until now, the Trump officials who’ve led the federal government’s coronavirus response have escaped the wrath of Congress. Here’s what STAT would ask.
- 05/11/2020
|
Dividend Increases: May 2-8, 2020
- This weekly article series covers dividend increase announcements. A summary table provides relevant data and key statistics. As a bonus, I include ex-dividend
- 05/11/2020
|
S&P 5…… and Nasdaq Gain on Monday
|
Dividend Champion And Contender Highlights: Week Of May 10
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which declared increased dividends. Companies with upcoming ex-dividend d
- 05/09/2020
|
Infectious-disease doctors ask government to explain how it decides who gets Gilead’s remdesivir
- Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to clarify how it is selecting which hospitals get access to the drug.
- 05/09/2020
|
Plan to distribute Covid-19 drug unveiled amid concerns over allocation
- The federal government’s new plan would deliver remdesivir to state health departments and allow them to determine which hospitals should receive it.
- 05/09/2020
|
UCSF medical workers question federal distribution of COVID-19 medicine
- University pharmacists were shocked when they learned that they would not be getting any of the 1.5 million doses of the drug remdesivir, which is being distributed to hospitals nationwide.
- 05/09/2020
|
Newsflash: Even After COVID-19 The Market Is Not Cheap
- As time has passed analysts have had the opportunity to assess the Covid-19 potential damage to the S&P 500’s earnings. Because of this updated forecast, I no l
- 05/08/2020
|
AmerisourceBergen Corp (NYSE: ABC) Q2 2020 Earnings Call Transcript | AlphaStreet
- Final earnings conference call transcript of AmerisourceBergen Corp. - ABC stock
- 05/08/2020
|
Morgan Stanley Maintains Equal-Weight on AmerisourceBergen, Raises Price Target to $94
|
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
- Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Computer Programs and Systems Inc : Cantor Fitzgerald raises to overweight from neutral
* Epam Systems Inc : Citigroup raises price target to $265 from $245
* PayPal Holdings Inc : Citigroup raises price target to $145 from $131
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical
order.
* Aaron's Inc : Keybanc cuts target price to $55 from $66
* Aaron's Inc : Raymond James cuts target price to $50 from $60
* Aaron's Inc : Stephens raises target price to $45 from $26
* Abeona Therapeutics Inc : RBC cuts target price to $7 from $11
* Acceleron pharma Inc : Credit Suisse raises target price to $123 from $99
* ACI Worldwide Inc : Canaccord Genuity cuts target price to $35 from $44
* Acushnet Holdings Corp : Jefferies raises target price to $25 from $24
* Acushnet Holdings Corp : JP Morgan raises target price to $30 from $27
* Adtran Inc : Cowen and Company raises price target to $13 from $9
* Aeglea Bio Therapeutics Inc : Needham cuts price target to $11 from $14
* Aerie Pharmaceuticals Inc : Citigroup cuts price target to $38 from $39
* Agco Corp : Citigroup cuts price target to $55 from $57
* AIG : KBW raises target price to $36 from $35
* Alaska Air Group Inc : Credit Suisse cuts target price to $51 from $82
* Allison Transmission Holdings Inc : Citigroup raises price target to $39 from $38
* Allscripts Healthcare Solutions : Cantor Fitzgerald cuts PT to $6 from $8
* Alteryx Inc : Guggenheim cuts target price to $130 from $160
* American Airlines : Credit Suisse cuts target price to $4 from $26
* Ameriprise Financial Inc : Credit Suisse raises target price to $165 from $153
* Ameriprise Financial Inc : Piper Sandler raises target price to $150 from $130
* Amerisourcebergen Corp : Baird raises target price to $115 from $109
* Amerisourcebergen Corp : Mizuho raises target price to $90 from $85
* Amtech Systems Inc : Cowen and Company raises target price to $7.50 from $7
* Angi Homeservices Inc : Needham raises target price to $11 from $8
* Ani Pharmaceuticals Inc : Guggenheim cuts target price to $48 from $58
* Ansys Inc : RBC raises target price to $260 from $230
* Anthem Inc : Bernstein raises target price to $357 from $342
* Appian Corp : Cowen and Company raises price target to $44 from $39
* Applied Optoelectronics Inc : D.A. Davidson raises target price to $12 from $10
* Applied Optoelectronics Inc : Piper Sandler raises target price to $10 from $7.50
* Aptiv Plc : Citigroup raises price target to $84 from $67
* ArcelorMittal SA : Keybanc raises target price to $15 from $13
* Arcturus Therapeutics Holdings Inc : Baird raises target price to $44 from $26
* Arcturus Therapeutics Holdings Inc : Guggenheim raises target price to $51 from $41
* Ares Capital Corp : Citigroup raises price target to $15 from $13
* Athersys Inc : Needham cuts price target to $5 from $6
* Atlas Air Worldwide Holdings Inc : Cowen and Company raises PT to $44 from $40
* Avalara Inc : Canaccord Genuity raises target price to $115 from $105
* Avalara Inc : JP Morgan raises target price to $120 from $104
* Avalara Inc : Mizuho raises price target to $120 from $85
* Avalara Inc : Piper Sandler raises target price to $113 from $90
* Avalonbay Communities Inc : Stifel raises target price to $176 from $171
* Avrobio Inc : Guggenheim raises target price to $50 from $49
* Axalta Coating Systems Ltd : RBC raises target price to $21 from $20
* Bausch Health Companies Inc : Piper Sandler cuts target price to $32 from $34
* Beacon Roofing Supply Inc : SunTrust Robinson raises target price to $26 from $24
* Beacon Roofing Supply Inc : Wedbush raises target price to $23 from $16
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Becton Dickinson and Co : Evercore ISI raises target price to $270 from $255
* Beyond Meat Inc : Berenberg raises price target to $125 from $115
* Bill.Com Holdings Inc : Canaccord Genuity raises target price to $65 from $50
* Bill.Com Holdings Inc : Jefferies raises target price to $70 from $45
* Bill.Com Holdings Inc : Keybanc raises target price to $76 from $60
* Bill.Com Holdings Inc : Needham raises target price to $90 from $55
* Biomarin Pharmaceutical Inc : Canaccord Genuity raises PT to $119 from $108
* BJ's Restaurants Inc : Wedbush cuts target price to $32 from $39
* Booking Holdings Inc : Credit Suisse raises target price to $1,810 from $1,790
* Booking Holdings Inc : Jefferies cuts target price to $1300 from $1350
* Booking Holdings Inc : Mizuho cuts price target to $1700 from $1720
* Booking Holdings Inc : RBC raises target price to $1,550 from $1,535
* Booking Holdings Inc : RBC raises target price to $1550 from $1535
* BorgWarner Inc : Citigroup raises price target to $30 from $23
* BorgWarner Inc : Credit Suisse raises target price to $33 from $31
* Bottomline Technologies (De) Inc : Citigroup raises price target to $46 from $43
* Bright Horizons Family Solutions Inc : Citigroup raises PT to $122 from $80
* Brightsphere Investment Group Inc : Evercore ISI raises target to $9 from $6
* Brightsphere Investment Group Inc : KBW raises target price to $9.50 from $7.25
* Brightview Holdings Inc : Credit Suisse cuts target price to $14 from $18
* Brightview Holdings Inc : Jefferies raises target price to $14 from $12
* Cabot Microelectronics Corp : Citigroup cuts price target to $140 from $175
* Cactus Inc : zephirin Group raises price objective to $12 from $8
* Calithera Biosciences Inc : Jefferies raises target price to $9 from $6
* Calyxt Inc : BMO cuts price target to $7 from $13
* Calyxt Inc : BMO cuts to market perform from outperform
* Camping World Holdings Inc : Credit Suisse raises target price to $12 from $11
* Camping World Holdings Inc : JP Morgan raises price target to $11 from $10
* Capstar Financial Holdings Inc : KBW raises target price to $11 from $10.50
* Cargurus Inc : BTIG raises target price to $26 from $23
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Castlight Health Inc : Cantor Fitzgerald cuts target price to $1 from $2
* Catasys Inc : Canaccord Genuity raises target price to $36 from $35
* CBRE Group Inc : Evercore ISI cuts target price to $48 from $50
* CBRE Group Inc : KBW cuts target price to $51 from $52
* Centerpoint Energy Inc : Guggenheim raises target price to $26 from $25
* Centerpoint Energy Inc : Keybanc raises target price to $16 from $12
* Centurylink Inc : RBC cuts target price to $10 from $14
* CF Industries Holdings Inc : Citigroup cuts price target to $29 from $31
* CF Industries Holdings Inc : Scotiabank raises target price to $32 from $31
* ChannelAdvisor Corp : Needham raises price target to $14 from $11
* Charles River Laboratories International : Credit Suisse cuts PT to $159 from $162
* Charles River Laboratories International : Evercore ISI ups PT to $176 from $154
* Charles River Laboratories International : Jefferies raises PT to $161 from $139
* Charles River Laboratories International Inc : Citigroup raises price target to $190 from $165
* Chart Industries Inc : zephirin Group raises price objective to $25 from $17
* Charter Communications Inc : Benchmark raises price target to $600 from $523
* Chemours Co : Citigroup raises price target to $13 from $8
* Cimarex Energy Co : MKM Partners raises target price to $34 from $31
* City Holding Co : Stephens cuts target price to $63 from $64.
- 05/08/2020
|
Edited Transcript of ABC earnings conference call or presentation 7-May-20 12:30pm GMT
- Q2 2020 AmerisourceBergen Corp Earnings Call
- 05/07/2020
|
Infectious-disease doctors ask government to explain how it decides who gets Gilead’s remdesivir
- Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to clarify how it is selecting which hospitals get access to the drug.
- 05/07/2020
|
AmerisourceBergen Corp (ABC) Q2 2020 Earnings Call Transcript
- Good morning, and thank you all for joining us for this conference call to discuss AmerisourceBergen's Fiscal 2020 Second Quarter results. On today's call, we will be discussing non-GAAP financial measures.
- 05/07/2020
|
U.S. Doctors want details on federal distribution of Gilead coronavirus drug
- The Infectious Disease Society of America (IDSA) is asking for more information on the federal government's plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus.
- 05/07/2020
|
U.S. Doctors want details on federal distribution of Gilead coronavirus drug
- The Infectious Disease Society of America (IDSA) is asking for more information on the federal government's plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus.
- 05/07/2020
|
Doctors want details on federal distribution of Gilead coronavirus drug
- The Infectious Disease Society of America (IDSA) is asking for more information on the federal government's plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus.
- 05/07/2020
|
Doctors want details on federal distribution of Gilead coronavirus drug
- The Infectious Disease Society of America (IDSA) is asking for more information on the federal government's plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus.
- 05/07/2020
|
Travel Sites Take a Hit from the Pandemic -- -2-
|
Infectious disease doctors ask government to explain how it decides who gets Gilead’s remdesivir
- Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to...
- 05/07/2020
|
AmerisourceBergen's (ABC) CEO Steve Collis on Q2 2020 Results - Earnings Call Transcript
- AmerisourceBergen Corporation (NYSE:ABC) Q2 2020 Earnings Conference Call May 07, 2020, 08:30 AM ET Company Participants Bennett Murphy – Head-Investor Relation
- 05/07/2020
|
The Case For AmerisourceBergen Corporation (NYSE:ABC): Could It Be A Nice Addition To Your Dividend Portfolio?
- Is AmerisourceBergen Corporation (NYSE:ABC) a good dividend stock? How can we tell? Dividend paying companies with...
- 05/07/2020
|
AmerisourceBergen (ABC) Q2 Earnings & Revenues Top Estimates
- AmerisourceBergen's (ABC) fiscal second-quarter earnings benefit from segmental growth.
- 05/07/2020
|
